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ABASTRACT 
 
          This study was designed to investigate the anti-diarrhoeal activity 
of the orally administrated extract of Hydnora abyssinica roots at 
different doses to rats. The anti-diarrhoeal potential of plant extract was 
tested in rats by faecal mass inhibition. The toxicity of the plant extract 
was also tested at different doses to rats via oral route. 
          The aqueous extract of Hydnora abyssinica was tested using 
twenty- four Albino rats arranged in five groups (control+ 3 test groups + 
loperamide group) receiving oral dose rates of 100, 200 and 400 mg 
extract/kg body weight/rat, 3 mg loperamide (reference anti-diarrhoeal 
drug)/kg body weight/rat and 1 ml/kg body weight/rat of normal saline 
(control). All individuals were given orally, 30 minutes subsequent to 
extract administration, acute diarrhoea inducer (1 ml castor oil /kg body 
weight/rat). Cumulative wet faecal mass was weighed for assessment of 
diarrhoea state at 4 and 6 hours.  
          The safety of the extract was also tested, using twenty Albino rats 
distributed in four groups (control + 3 test groups) given oral dose of 400, 
800 and 1600 mg extract/kg body weight/rat/day, continued for seven 
days. 
The aqueous extract of Hydnora abyssinica showed significant 
(P<0.05) anti-diarrhoeal activity against castor oil induced diarrhoea in 
all rats with reduction rates of 46.78%, 63.21% and 74.68% for the doses 
100, 200 and 400 mg/kg body weight respectively at 4th hrs post 
treatment and these doses rates recorded inhibition rates of 27.42%, 
50.88% and 60.13% at 6th hours respectively post treatment.  
          Clinical signs were observed regularly. Sera were analyzed for 
enzymatic activities of AST, ALT and metabolic indicators such as total 
protein, albumin, sodium, potassium and calcium. Also, changes in values 
 xi
of  RBCS, Hb, PCV, MCV and MCHC were recorded. The weight of 
faeces was recorded too for assessment of diarrhoeal inhibition. 
          In both experiments, clinically no signs of toxicity were observed, 
no deaths or gross changes in the examined vital organs. 
         Metabolic indicators; total protein, potassium and calcium 
demonstrated significant increase while sodium and albumin showed no 
significant changes at dose 400 mg/kg. 
In haematological parameters there were significant decrease in 
values of RBCs, PCV and MCHC while Hb concentration showed 
significant increase. MCV values indicated no changes. 
         Plant extract’s safety showed no significant change in the serum 
(ALT) activity while in (AST) activity there was significant increase. In 
serum metabolites, there were no changes in the concentration of total 
protein and albumin when compared with the un-dosed control group at 
the end of the experiment. The concentration of sodium and potassium 
showed significant increase. 
There were significant decrease in the concentration of 
haematological parameters tested; RBCS, Hb and PCV. MCHC showed 
significant increase, while MCV values demonstrated no changes.  
The results were discussed with suggestions for future studies. 
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 ﺑﺴﻢ ﺍﷲ ﺍﻟﺮﺣﻤﻦ ﺍﻟﺮﺣﻴﻢ
  
  ﻤﺴﺘﺨﻠﺹﺍﻟ
ﻟﻨﺒﺎﺕ  ﻰﺴﻬﺎل ﻟﻠﻤﺴﺘﺨﻠﺹ ﺍﻟﻤﺎﺌﻗﺩﺭﺓ ﺘﻀﺎﺩ ﺍﻹ ﺭﺨﺘﺒﺎﺔ ﻹﺼﻤﻤﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴ        
ﻯ ﻭﺫﻟﻙ ﺒﻘﻴﺎﺱ ﻨﺴﺒﺔ ﻟﻔﺌﺭﺍﻥ ﻋﺒﺭ ﺍﻟﺘﺠﺭﻴﻊ ﺍﻟﻔﻤﻭ، ﻓﻰ ﺍﺨﺘﻠﻔﺔﺎﺕ ﻤﺒﺠﺭﻋ ،ﺍﻟﺘﺭﺘﻭﺱ
 ﻰ ﻟﻠﻨﺒﺎﺕﺴﻤﻴﺔ ﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻤﺎﺌ ﻴﻀﺎﹰﺃ ﺨﺘﺒﺭﺕﺇ .ﺍﻟﺘﺜﺒﻴﻁ ﺍﻟﻨﺎﺘﺞ ﻓﻰ ﻭﺯﻥ ﺍﻟﺒﺭﺍﺯ ﺍﻟﻜﻠﻰ
  .ﻋﻦ ﻃﺮﻳﻖ اﻟﻔﻢ ﺍﻟﻔﺌﺭﺍﻥ ﻰﻓ
 ﺒﺎﺴﺘﺨﺩﺍﻡﻟﻨﺒﺎﺕ ﺍﻟﺘﺭﺘﻭﺱ  ﻰﻟﻠﻤﺴﺘﺨﻠﺹ ﺍﻟﻤﺎﺌ ﺴﻬﺎلﻓﻌﺎﻟﻴﺔ ﺘﻀﺎﺩ ﺍﻹ ﺕﺭﺨﺘﺒﺇ        
 +ﺨﺘﺒﺎﺭﺇ ﻤﺠﻤﻭﻋﺎﺕ 3+ ﻤﺠﻤﻭﻋﺔ ﺴﻴﻁﺭﺓ ) ﻤﺠﻤﻭﻋﺎﺕﺨﻤﺱ  ﻰﻓ ﺒﻴﻀﺎﹰﺃ ﻓﺄﺭﺍﹰ 42
ﻜﺠﻡ /ﻤﻠﺠﺭﺍﻡ 004ﻭ 002، 001 ﺠﺭﻋﺎﺕﺍﻟ ﻓﻤﻭﻴﺎﹰ ﺃﻋﻁﻴﺕ (ﻠﻭﺒﺭﺍﻤﻴﺩﺍﻟ ﻤﺠﻤﻭﻋﺔ
ﻜﺠﻡ ﻭﺯﻥ (/ﺴﻬﺎﻻﺕﺇﻤﺭﺠﻊ ﺘﻀﺎﺩ ﺩﻭﺍﺀ )ﻤﻠﺠﺭﺍﻡ ﻟﻭﺒﺭﺍﻤﻴﺩ  3 ،ﻓﺄﺭ/ ﻰﻭﺯﻥ ﺤ
ﻤﺠﻤﻭﻋﺔ )ﻟﻤﻠﺢ ﺍﻟﻁﻌﺎﻡ   ﻯﻥ ﺍﻟﻤﺤﻠﻭل ﺍﻟﻌﺎﺩﻓﺄﺭ ﻤ/ﻰﻭﺯﻥ ﺤ/ﻜﺠﻡ/ﻤل1ﻓﺄﺭ ﻭ/ﻰﺤ
 ﺍﻟﻔﺌﺭﺍﻥﺘﻡ ﺘﺠﺭﻴﻊ ﺠﻤﻴﻊ  ﻴﻘﺔ ﻤﻥ ﺇﻋﻁﺎﺀ ﻤﺴﺘﺨﻠﺹ ﺍﻟﻨﺒﺎﺕﺩﻗ 03ﻗﺒل  .(ﺍﻟﺴﻴﻁﺭﺓ
ﺍﻟﺒﺭﺍﺯ ﻭﺯﻥ  ﺘﻡ .(ﻓﺄﺭ ﺯﻴﺕ ﺨﺭﻭﻉ/ﻰﻜﺠﻡ ﻭﺯﻥ ﺤ/ﻤل 1) ﻰﺴﻬﺎل ﻤﻭﻀﻌﺇﺒﻤﺴﺒﺏ 
 ﻓﻌﺎﻟﻴﺔ ﻟﺘﻘﻴﻴﻡ ﺔﺴﺎﻋﺃﺭﺒﻊ ﻭﻋﺸﺭﻭﻥ ﺭﺒﻊ ﺴﺎﻋﺎﺕ ﻭﺴﺕ ﺴﺎﻋﺎﺕ ﻭﺃﺒﻌﺩ  ﺍﻟﻨﺎﺘﺞ
  .ﺴﻬﺎلﺍﻹ ﺘﻀﺎﺩ ﻓﻰ ﻟﻤﺴﺘﺨﻠﺹﺍ
 ﻓﺄﺭﺍﹰ 02 ﺘﺭﺘﻭﺱ ﺒﺎﺴﺘﺨﺩﺍﻡﻟﻨﺒﺎﺕ ﺍﻟ ﻰﺴﻤﻴﺔ ﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻤﺎﺌ ﺨﺘﺒﺎﺭﺇ ﻴﻀﺎﹰﺃﺘﻡ         
، 004 (ﺭﺨﺘﺒﺎﺇ ﻤﺠﻤﻭﻋﺎﺕ 3+ ﻤﺠﻤﻭﻋﺔ ﺴﻴﻁﺭﺓ )ﺭﺒﻊ ﻤﺠﻤﻭﻋﺎﺕ ﺃ ﻰﻓ ﺒﻴﻀﺎﹰﺃ
  .ﻴﺎﻡﺃ 7ﺍﻟﻴﻭﻡ ﻭﻟﻤﺩﺓ /ﻓﺄﺭ/ﻰﻜﺠﻡ ﻭﺯﻥ ﺤ/ﻤﻠﺠﺭﺍﻡ 0061ﻭ 008
ﻗﺩﺭﺓ  ﻓﻰ (50.0>ﺃ)ﻤﻌﻨﻭﻴﺔ  ﺔﺍﻟﺘﺭﺘﻭﺱ ﻓﻌﺎﻟﻴﻟﻨﺒﺎﺕ  ﻰﻅﻬﺭ ﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻤﺎﺌﺃ       
ﻭﺫﻟﻙ ﻓﻰ  ﺍﻟﻨﺎﺘﺞ ﺍﻟﺒﺭﺍﺯﻭﺯﻥ  ﻴﻁﺒﺘﺜﺒ ﺍﻟﻨﺎﺘﺞ ﻭﺍﻟﻤﺘﺴﺒﺏ ﺒﺯﻴﺕ ﺍﻟﺨﺭﻭﻉ ﺴﻬﺎلﺘﻀﺎﺩ ﺍﻹ
ﻓﻰ ﺍﻟﺴﺎﻋﺔ ﺍﻟﺭﺍﺒﻌﺔ ﻓﺄﺭ/ﻰﻜﺠﻡ ﻭﺯﻥ ﺤ/ﻤﻠﺠﺭﺍﻡ 004ﻭ 002، 001ﺠﻤﻴﻊ ﺍﻟﺠﺭﻋﺎﺕ 
ﻋﻠﻰ % 86.47ﻭ% 12.36 ،%17.64 ﺘﻨﺎﻗﺹ ﻨﺴﺒﺔ ﻤﻌﻁﻴﺎﹰ ﺒﻌﺩ ﺍﻟﻤﻌﺎﻟﺠﺔ ﻟﻠﺭﺼﺩ
ﻨﺴﺒﺔ ﺒ ﺒﻌﺩ ﺍﻟﻤﻌﺎﻟﺠﺔ ﺃﻅﻬﺭ ﺘﻨﺎﻗﺼﺎﹰ ﻤﻌﻨﻭﻴﺎًﹰ ﺍﻟﺘﻭﺍﻟﻰ ﻭﻓﻰ ﺍﻟﺴﺎﻋﺔ ﺍﻟﺴﺎﺩﺴﺔ ﻟﻠﺭﺼﺩ
ﻜل ﺍﻟﻔﺌﺭﺍﻥ ﺍﻟﻤﺘﺒﻘﻴﺔ ﺫﺒﺤﺕ ﻓﻰ  .ﺍﻟﺘﻭﺍﻟﻰ ﻋﻠﻰ %31.06ﻭ% 85.05, %24.72
ﻋﺭﺍﺽ ﺘﻤﺕ ﻤﺭﺍﻗﺒﺔ ﺍﻷ .ﻋﻀﺎﺀ ﺍﻟﺤﻴﻭﻴﺔﺍﻷ ﻰﺘﻐﻴﺭ ﻓﺍﻟ ﺔﻼﺤﻅﻤﻟﻨﻬﺎﻴﺔ ﺍﻟﺘﺠﺭﺒﺔ 
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ﺘﺭﻜﻴﺯ ﻨﺎﻗل ﺍﻟﻘﻠﻭﺘﺎﻤﻴﺕ ﺃﻭﻜﺴﺎﻟﻴﺕ  ﺘﻡ ﺘﺤﻠﻴل ﺍﻟﻤﺼل ﻟﻜﺸﻑ .ﻨﺘﻅﺎﻡﺄﻜﻠﻴﻨﻴﻜﻴﺔ ﺒﺍﻹ
 ﻰ،ﺍﻟﺒﺭﻭﺘﻴﻥ ﺍﻟﻜﻠ :ﻴﻀﻴﺔﻗﻴﻡ ﺍﻟﻤﺅﺸﺭﺍﺕ ﺍﻷ ﻴﻤﻴﻥ ﺍﻟﻘﻠﻭﺘﺎﻤﻴﺕ ﺒﻴﺭﻭﻓﻴﺕ ﻭﻜﺫﻟﻙﻭﻨﺎﻗل ﺇ
 ﻋﺩﺩ ﻰﺴﺠﻠﺕ ﻜﺫﻟﻙ ﺍﻟﺘﻐﻴﺭﺍﺕ ﻓ. ﺍﻟﻜﺎﻟﺴﻴﻭﻡﺴﻴﻭﻡ ﻭﺎﺍﻟﺒﻭﺘ ،ﺍﻟﺼﻭﺩﻴﻭﻡ ،ﻟﺒﻴﻭﻤﻴﻥﺍﻷ
ﺤﺠﻡ ﺍﻟﺨﻼﻴﺎ ﺍﻟﻤﺘﺭﺍﺹ، ﻤﺘﻭﺴﻁ ﺤﺠﻡ  ،ﻠﻭﺒﻴﻥﻭﺠﺍﻟﻬﻴﻤ ﺘﺭﻜﻴﺯ ،ﺍﻟﻜﺭﻴﺎﺕ ﺍﻟﺤﻤﺭﺍﺀ
   .ﻠﻭﺒﻴﻥ ﻟﻠﺨﻠﻴﺔﺠﺍﻟﺨﻼﻴﺎ ﻭﻤﺘﻭﺴﻁ ﺘﺭﻜﻴﺯ ﺍﻟﻬﻴﻤﻭ
 ﻟﻡ ﺘﻼﺤﻅ ﺃﻯ ﻋﻼﻤﺎﺕ ﺘﺴﻤﻡ، ﻤﻭﺕ ﺃﻭ ﺘﻐﻴﺭﺍﺕ ﻜﻠﻴﻨﻴﻜﻴﺎﹰﻓﻰ ﻜﻠﺘﺎ ﺍﻟﺘﺠﺭﺒﺘﻴﻥ ﺇ       
  .ﻤﺭﺌﻴﺔ ﻓﻰ ﺍﻷﻋﻀﺎﺀ ﺍﻟﺤﻴﻭﻴﺔ ﺍﻟﺘﻰ ﺘﻤﺕ ﻤﻌﺎﻴﻨﺘﻬﺎ
ﺃﻅﻬﺭﺕ  ﺍﻟﻜﺎﻟﺴﻴﻭﻡﺴﻴﻭﻡ ﻭﺎﺍﻟﺒﻭﺘ ﻰ،ﺍﻟﺒﺭﻭﺘﻴﻥ ﺍﻟﻜﻠﻗﻴﻡ ﺍﻟﻤﺅﺸﺭﺍﺕ ﺍﻷﻴﻀﻴﺔ ﻓﻰ       
ﻟﻡ ﺘﻅﻬﺭ ﺃﻯ ﺘﻐﻴﻴﺭ ﻤﻌﻨﻭﻯ ﺃﻤﺎ  ﻟﺒﻴﻭﻤﻴﻥﺍﻷﻭ  ﺍﻟﺼﻭﺩﻴﻭﻡ ﺯﻴﺎﺩﺓ ﻤﻌﻨﻭﻴﺔ ﺒﻴﻨﻤﺎ ﻗﻴﻡ
ﻤﺘﺭﺍﺹ ﺤﺠﻡ ﺍﻟﺨﻼﻴﺎ ﺍﻟ ،ﺍﻟﻜﺭﻴﺎﺕ ﺍﻟﺤﻤﺭﺍﺀ ﻋﺩﺩﺍﻟﺼﻭﺭﺓ ﺍﻟﺩﻤﻭﻴﺔ ﺃﻅﻬﺭﺕ ﻨﻘﺼﺎﻥ ﻓﻰ 
ﺯﻴﺎﺩﺓ  ﻠﻭﺒﻴﻥﻭﺠﺍﻟﻬﻴﻤ ﺘﺭﻜﻴﺯ ﺃﻅﻬﺭ ﺒﻴﻨﻤﺎ  ﻠﻭﺒﻴﻥ ﻟﻠﺨﻠﻴﺔﺠﻭﻤﺘﻭﺴﻁ ﺘﺭﻜﻴﺯ ﺍﻟﻬﻴﻤﻭ
  . ﻅﻬﺭ ﺃﻯ ﺘﻐﻴﻴﺭ ﻤﻌﻨﻭﻯﻴﻟﻡ  ﻤﺘﻭﺴﻁ ﺤﺠﻡ ﺍﻟﺨﻼﻴﺎ  ﺃﻤﺎ ﻤﻌﻨﻭﻴﺔ
ﻟﻡ ﺘﻭﺠﺩ ﺘﻐﻴﺭﺍﺕ ﻤﻌﻨﻭﻴﺔ  ﻟﻨﺒﺎﺕ ﺍﻟﺘﺭﺘﻭﺱ ﻰﺴﻤﻴﺔ ﺍﻟﻤﺴﺘﺨﻠﺹ ﺍﻟﻤﺎﺌ ﺨﺘﺒﺎﺭﺇ ﻋﻨﺩ      
ﻴﻤﻴﻥ ﻨﺎﻗل ﺇ ﻨﺸﺎﻁ ﺘﺭﻜﻴﺯ ﻨﺎﻗل ﺍﻟﻘﻠﻭﺘﺎﻤﻴﺕ ﺃﻭﻜﺴﺎﻟﻴﺕ ﻓﻰ ﺍﻟﻤﺼل ﺃﻤﺎ ﻓﻰ ﻨﺸﺎﻁ
ﺘﺤﻠﻴل ﺍﻟﻤﺼل ﺃﻅﻬﺭ ﻋﺩﻡ ﻭﺠﻭﺩ ﺘﻐﻴﻴﺭ ﻓﻰ . ﺃﻅﻬﺭ ﺯﻴﺎﺩﺓ ﻤﻌﻨﻭﻴﺔ ﺍﻟﻘﻠﻭﺘﺎﻤﻴﺕ ﺒﻴﺭﻭﻓﻴﺕ
ﻤﻥ ﺠﻬﺔ ﺃﺨﺭﻯ . ﺘﺭﻜﻴﺯ ﺍﻟﺒﺭﻭﺘﻴﻥ ﺍﻟﻜﻠﻰ ﻭ ﺍﻷﺒﻴﻭﻤﻴﻥ ﻤﻘﺎﺭﻨﺔ ﻤﻊ ﻤﺠﻤﻭﻋﺔ ﺍﻟﺴﻴﻁﺭﺓ
ﺃﻤﺎ ﺍﻟﺼﻭﺭﺓ ﺍﻟﺩﻤﻭﻴﺔ . ﻫﻨﺎﻙ ﺯﻴﺎﺩﺓ ﻤﻌﻨﻭﻴﺔ ﻓﻰ ﺘﺭﻜﻴﺯ ﺍﻟﺼﻭﺩﻴﻭﻡ ﻭ ﺍﻟﺒﻭﺘﺎﺴﻴﻭﻡ
ﺤﺠﻡ  ،ﻠﻭﺒﻴﻥﻭﺠﺍﻟﻬﻴﻤ ﺘﺭﻜﻴﺯ ،ﻟﻜﺭﻴﺎﺕ ﺍﻟﺤﻤﺭﺍﺀﺍ ﻋﺩﺩﻤﻌﻨﻭﻯ ﻓﻰ  ﺃﻅﻬﺭﺕ ﻨﻘﺼﺎﻥ
 ﺒﻴﻨﻤﺎ ﺯﻴﺎﺩﺓ ﻤﻌﻨﻭﻴﺔ ﺃﻅﻬﺭ ﻠﻭﺒﻴﻥ ﻟﻠﺨﻠﻴﺔﺠﻤﺘﻭﺴﻁ ﺘﺭﻜﻴﺯ ﺍﻟﻬﻴﻤﻭ ﺃﻤﺎ ،ﺍﻟﺨﻼﻴﺎ ﺍﻟﻤﺘﺭﺍﺹ
  .ﻟﻡ ﻴﻅﻬﺭ ﺃﻯ ﺘﻐﻴﻴﺭ ﻤﻌﻨﻭﻯ  ﻤﺘﻭﺴﻁ ﺤﺠﻡ ﺍﻟﺨﻼﻴﺎ
 .ﺘﻤﺕ ﻤﻨﺎﻗﺸﺔ ﺍﻟﻤﻨﺎﺤﻰ ﺍﻟﺘﻁﺒﻴﻘﻴﺔ ﻭﺍﻟﻤﻘﺘﺭﺤﺎﺕ ﺍﻟﻤﺴﺘﻘﺒﻠﻴﺔ ﻟﻠﺩﺭﺍﺴﺔ     
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INTRODUCTION 
 
Plants have been used for thousands years for many different 
purposes ranging from medicinal to religious (in rituals) and from 
protection against spirits to culinary delights‚ perfumery and cosmetics 
(EL Ghazali et al.‚ 2004). They contain a number of chemical 
constituents such as alkaloids‚ flavonoids‚ tannins‚ saponins‚ glycosides 
and others‚ which have been isolated and used as an important source of 
indispensable drugs. Clarke et al. (1981) stated that medicinal plants are 
known by their required clinical effects on the abnormal living tissues or 
organs while toxic ones are known by their ability to cause a non required 
physiological deviation in animals’ bodies.  
However, medicinal plants are now being given a serious attention 
as is evidenced in 1970 by the recommendation given by the World 
Health Organization (WHO), that proven traditional remedies should be 
incorporated within national drug policies (Wondergen et al.‚1989) and 
since 1976, the traditional medicine programme of (WHO) as a source of 
Primary Health Care (PHC) has been globally addressed (Rukangira‚ 
2001).  
A list of 20.000 medicinal plants used worldwide is prepared by the 
(WHO) and indicated that 4.000 plant origin drugs are used in a wide 
range through out the world thus, recognition and development of 
medical and economic benefits of traditional medicinal plants are on 
increase in both developing and industrialized countries (WHO, 1998). In 
a country like China‚ with its all this population‚ plants extracts which 
have been used for centuries, are still the main type of drug therapy. A 
survey showed that there are 7295 species of plants used medicinally in 
China (Ciba Found‚ 1994). 
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In East African, Koko Waro‚ (1976) reported that both literate and 
illiterate people still use local plants as drugs in many conditions. Plants 
were also traditionally prescribed and used for generations and centuries 
with slight or almost no changes and with strong beliefs in North Africa‚ 
leading in most cases to satisfactory results (Boulos‚ 1983).  
Sudan‚ the largest country in Africa‚ has a wide diversity climate 
which is responsible for its varied vegetation and very rich flora. Many 
species of plants grow abundantly in the Sudan and other African 
countries and are used by the village populations for treatment of various 
disorders (Adam‚ 1978 and Nwude‚1979).  
          The Sudanese folkloric medicine represents a unique blend of 
indigenous cultures with Egyptian‚ Indian‚ Arabian‚ East and West 
African cultures (Gamal et al.‚ 1997). However‚ it is of paramount 
importance that people remain aware of the dangers caused by plants 
which are utilized for medicinal purposes and need to validate their 
safety, this lead researchers to study more about these plants to determine 
their mode of action and pharmaceutical values. However, the results of 
many researches in Sudan demonstrated potentials for control of pests‚ 
schistosomiasis‚ fascioliasis‚ malaria‚ diabetes and other important 
diseases.  
One of the most serious health problems in both man and animals 
is diarrhoea which occurs in all age groups‚ especially in the young. In 
new born farm animals‚ diarrhoea is one of the most common disease 
complexes. Diarrhoea also is one of the most commonly observed 
abnormalities in faecal consistency and frequency of defecation 
(Radostits et al.‚ 2000). It is a significant cause of economic loss 
especially in cattle herds and may assume even greater importance as 
livestock becomes more intensified. The economic loss is due not only to 
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mortalities‚ but also to medical costs and poor growth (Woode and 
Crouch‚ 1978).  
          Snodgrass (1981) reported that 73% of neonatal mortalities of 
calves in a Libyan farm were caused by neonatal calves’ diarrhoea. In a 
Sudanese diary herd of local zebu breads belonging to the University of 
Khartoum, Wakeen and Dansoury (1962) reported a calf mortality rate of 
19% during the period 1944 to 1961, 70.3 % of the total deaths were 
chiefly due to scours and enteritis.   
          Diarrhoeal diseases are also identified as the largest single cause of 
death among children in the developing countries (Cruickshank‚ 1973). 
Indeed diarrhoea produces more illness and causes death of more infants 
and children than all other diseases combined (Weber, 1976) and still 
diarrhoea is one of the leading causes of morbidity and mortality of 
children less than 5 years worldwide, causing about one billion episodes 
of illness and 3−5 million deaths annually (WHO, 1980 and Behrman et 
al., 2004). To combat the problem of diarrhoea in developing countries, 
the world health organization (WHO) has constituted a diarrhoea disease 
control programme (DDC) which includes studies of traditional medicine 
practices together with the evaluation of health education and prevention 
approaches (Syder and Merson, 1982). 
The two main dangers of diarrhoea are death and malnutrition. 
Death from acute diarrhoea is commonly due to dehydration. Another 
important cause of death is dysentery which causes damage to the 
intestine by systemic infection and malnutrition (WHO‚ 1992).  
It is important to note that many of the organisms which cause 
scours in livestock can cause disease in humans (Schoenian‚ 2009). 
Hence calves scour and diarrhoeal diseases in children caused by various 
agents including E. coli are becoming a health problem worldwide 
including Sudan (Lambert‚ 1979 and Puent and Finlay‚ 2001).  
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          In Sudan, the mortality rate among children was estimated as 9% 
and more than half of this percentage was due to diarrhoeal diseases (Abd 
El Gadir, 2004) while mortality rate among calves was estimated to be 
10% and in some months it may reach 100% due to diarrhoea (Ali‚ 2000).  
          Despite the emergence of a number of drugs‚ none has found a 
place in the successful management of diarrhoea (Farthing‚ 2002). 
Therefore‚ there is need for continuous search for drugs that might inhibit 
the process of diarrhoea development. Rani et al. (1999) stated that 
medicinal plants are promising a source of anti-diarrhoeal drugs. Thus 
medicinal plants are one of the useful areas of research in this regard and 
which are believed to possess anti-diarrhoeal activities, are used in most 
of the developing countries in the management of diarrhoea.                                                
The popular medicinal plant Hydnora abyssinica, which is known 
locally as (Tartous), has grown abundantly in the tropical regions as well 
as in Sudan. The infusion of the roots powder is traditionally used in 
folkloric medicine for various disorders especially in treatment of 
diarrhoea and dysentery. However‚ this has not been confirmed and no 
previous scientific literature was found on its anti-diarrhoeal activity. 
Hence, the present study has been designed to investigate the anti-
diarrhoeal activity of the roots extract of Hydnora abyssinica in 
experimentally-induced diarrhoea model in rats and to test its toxicity to 
rats.  
The objectives of the study are to:   
• Evaluate the anti-diarrhoeal potential of the aqueous extract of 
Hydnora abyssinica (Tartous) roots against castor oil induced 
diarrhoea in rats.  
• Investigate the safety of Hydnora abyssinica roots aqueous extract 
when administrated orally to rats at different doses. 
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CHAPTER ONE 
LITRITURE REVEW 
1. 1   Definition of diarrhoea  
In medicine diarrhea (from the Greek‚ ″diarrhoia″ meaning ″a 
flowing through″, Medterms dictionary, 2007)‚ also spelled diarrhoea‚ is 
the condition of having frequent loose or liquid bowel movements.  
According to Heywarth‚ (1985); Martin Richard, (1989); Radostits 
et al.‚ (2000) and Schoenian‚ (2009)  diarrhoea is the increased frequency 
of defecation accompanied by faeces which contain an increased 
concentration of water and decrease in dry matter content. The volume of 
faecal excretion is also, increased. The consistency of the faeces varies 
from soft to liquid. They may contain blood or mucous, be smelly and the 
colour may be abnormal.       
Abnormalities of peristalsis and segmentation usually occur 
together and when there is a general increase in peristaltic activity‚ there 
is increased caudal flow resulting in a decrease in intestinal transit time 
and diarrhoea. Because of a lack of absorption of fluid the faeces are 
usually softer than normal‚ the dry matter content is below the normal 
range‚ and the total amount of faeces passed per day is increased. The 
frequency of defecation is usually also increased. 
However‚ it is difficult to define diarrhoea exactly‚ since there is 
great individual variation in normal stool frequency.  
1. 2 Types of diarrhoea  
          According to duration and episode‚ three clinical syndromes of 
diarrhoea have been defined‚ each reflecting pathogenesis and requiring 
different approaches to treatment (WHO‚ 1992); these include:  
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1. 2. 1 Acute watery diarrhoea  
          It begins acutely for less than 14 days and the passage characterized 
by loose or watery stools without visible blood. Vomiting may occur and 
fever may be present (WHO‚ 1992). Acute diarrhoea usually happens due 
to faecal oral transmission of bacterial toxins‚ viruses and bacteria or 
protozoan organisms (Kasper et al.‚ 2005). 
1. 2 .2 Dysentery 
          This is diarrhoea with visible blood in the faeces. Important effects 
of dysentery include anorexia‚ rapid weight loss and damage to the 
intestinal mucosa by invasive bacteria (WHO‚ 1992).  
1. 2. 3 Persistent diarrhoea  
          This diarrhoea begins acutely‚ but of unusually long duration (at 
least 14 days). The episode may begin either watery diarrhoea or as 
dysentery. Marked weight loss is frequent. There is no single microbial 
cause for persistent diarrhoea (WHO, 1992).              
1. 3 CAUSES 
          There are many causes of diarrhoea in farm animals and    
depending upon the causative agent diarrhoea varies considerably in its 
severity. Most workers agreed with the observation that numerous agents 
were involved in the diarrhoea syndrome (Fernelius‚ 1973). Studies of 
Radostits et al.‚ (2000) showed that several infectious agents‚ 
environmental‚ nutritional‚ immunological and genetic factors were 
involved in precipitating this disease. 
1. 3. 1 Enteritis 
          The term enteritis is used to describe inflammation of the intestinal 
mucosa resulting in diarrhoea‚ sometimes dysentery‚ abdominal pain 
occasionally‚ varying degrees of dehydration and acid base imbalance‚ 
depending on the causes of the lesion‚ its severity and location. In many 
cases‚ gastritis also occur together with enteritis.  
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The enteropathogens most commonly found and extensively studied 
were:  
1. 3. 1. 1 Bacteria 
Enterotoxgenic Esherichia coli (ETEC) in newborns (Tzipori et 
al.‚ 1984) causes outbreaks commonly and usually colostral immune 
status determine survival, Salmonella spp. affect all ages; stress induced 
causing outbreaks (Radostits et al.‚ 2000) and clostridium perfringes 
(Dickie et al.‚ 1978) cause severely diarrhoea in different species; are the 
most commonly bacterial causes of diarrhoea while Mycobacterium 
paratuberculosis, Protueus spp., Pseudomonas spp., Actinobacillus equi  
and Treponema hyodysenteriae (swine dysentery)  are other causes of 
diarrhoea in specific species. 
1. 3. 1. 2 Viruses 
          Rotavirus and coronavirus are considered to be the most important 
causes of viral diarrhoea in new born farm animals ﴾ Blood et al. ‚ 1983; 
Janke, 1989) which result in explosive outbreaks. Transmissible 
gastroenteritis virus TGE causes severe outbreaks in piglets (Radostits et 
al.‚ 2000), bovine viral diarrhoea virus BVDV (mucosal disease virus 
MDV) in adult cattle (Lambert and Fernelius‚ 1968; Mebus, 1976), 
Malignant catarrhal virus and Rinder pest virus can also cause diarrhoea. 
1. 3. 1. 3 Fungi 
          Candida spp. causes diarrhoea in young animals following 
prolonged use of oral antibacterial (Radostits et al.‚ 2000). 
1. 3. 1. 4 Helminthes 
          Variety of helminthes such as Ostertagia spp.‚ Nematodirus spp.‚ 
Trichostrongylus spp.‚ Trichonema spp., Strongylus spp., Ascaris spp. 
and Trichuris suis result in diarrhoea in different animals’ species.  
 
 
 8
1. 3. 1. 5 Protozoa 
          Cryptosporidium spp. and Eimeria spp. are extracellular parasite 
that commonly causing diarrhoea (Pohlenz et al., 1978). 
1. 3. 2 Chemical agents  
Arsenic, fluorine, copper, sodium, chloride, mercury, molybdenum, 
nitrates, poisonous plants and mycotoxins in all ages with history of 
access to substances, diarrhoea outbreaks occur (Radostits et al.‚ 2000). 
1. 3. 3 Physical agents 
Sand, soil, silage and feed containing lactic acid (sour brewers’ 
grains) usually in mature cattle with history of access, cause diarrhoea 
outbreaks ﴾Blood et al. ‚ 1983).  
1. 3. 4 Nutritional deficiencies  
Copper deficiency conditioned by excess molybdenum usually in 
mature cattle on pasture with high levels of molybdenum, also iron 
deficiency in piglets result in diarrhoea (Radostits et al.‚ 2000). 
1. 3. 5 Dietary  
Most common in the neonatal animals when over fed on milk or 
with indigestion which usually occurs following a sudden change of diet 
particularly in animals at weaning time, in mature cows occur usually 
when move from dry pasture to lush pasture or when grains are added 
liberally to feedlot at first time. 
          Because of the relatively high cost of good quality skim milk 
powder, large quantities of both non milk proteins and carbohydrates are 
used in formulating milk replacers, while some calves in the large units 
can satisfactory digest the nutrients in these milk replacers, many cannot 
and this leads to high incidence of diarrhoea, secondary colibacillosis and 
enteric salmonellosis, loss of weight, emaciation and starvation (Radostits 
et al., 2000), so the use of large quantities of soybean protein and fish 
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protein concentration in milk replacer for calves will result in chronic 
diarrhoea and poor growth rates.   
1. 3. 6 Malabsorption 
          This is due to villous atrophy and in hypocuprosis (due to 
molybdenum excess). Malabsorption syndromes are being recognized 
with increased frequency in monogastric farm animals. In malabsorption 
there is usually diarrhoea‚ always failure to grow or maintain body 
weight‚ in spite of an apparently normal appetite and adequate diet.          
          Woode and Crouch‚ (1978) stated that during the stage of 
diarrhoea‚ the absorption was reduced 60 to 90%. 
          The location of the lesion in the intestinal tract may influence the 
severity of the enteritis or malabsorption. Lesions involving the small 
intestine are considered to be more acute and severe than those in the 
large intestine because approximately 75−80% of the intestinal fluids is 
absorbed by the small intestine and much lesser quantities by the large 
intestine. However‚ the horse is an exception; 95% of these fluids are 
reabsorbed by the large intestine. Studies of Radostits et al.‚ (2000) 
showed that any significant dysfunction of the absorptive mechanism of 
the large intestine of the horse would results in large losses of fluids and 
electrolyte. This may explain the rapid dehydration and circulatory 
collapse which occur in horses with colitis−X. 
1. 3. 7 Miscellaneous or Uncertain etiology 
          Radostits et al., (2000) reported more other causes that result in 
diarrhoea: 
• Excitements when take place leads to neurogenic diarrhoea.         
• Local structural lesion of the stomach or intestine including; ulcer 
of the abomasum or stomach, and tumer as intestinal 
adenocarcinoma.     
• Carbohydrate engorgement in cattle. 
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• In some cases of ileal hypertrophy‚ ileitis‚ diverticulitis and 
adenocarcimoma. 
• Terminal stages of congestive heart failure (visceral edema) or 
hepatic fibrosis.   
• Endotoxic mastitis in cattle (splanchnic congestion). 
• Vagus indigestion in cows causes pasty faeces but bulk is reduced. 
          These cases may be mistaken initially for other causes of diarrhoea. 
          Morin et al., (1978); Tzipori‚ (1981) and Radostits et al.‚ (2000) 
stated that diarrhoea can be attributed to infection with single or multiple 
agents. As diagnostic techniques are improved, multiple mixed infections 
are being recognized more frequently than single infection.  
          There appear to be some synergistic action between E. coli and 
viruses in the production of the typical infectious calf diarrhoeal disease 
(Amstutz‚ 1965). In experimental combined E. coli and rotavirus 
infection in lambs‚ the mortality is higher than when either of the two 
agents administered alone (Blood et al.‚ 1983). Baljer‚ (1986) suggested 
that more severe forms of diarrhoea are usually the result of mixed 
infections and recent research has identified a synergic effect between 
rotaviruses and enterotoxigenic E.coli.  
1. 4 Epidemiology and Predisposing agents 
          According to Quinin et al.‚ (1999) the predisposing causes are of 
paramount importance and to a large extent determine weather or not 
clinical signs of illness will occur.  
          Mebus, (1976) and Radostits et al.‚ (2000) reported that in addition 
to the primary etiological agents of diarrhoea‚ there are many influences 
exerted by the host and the environment which can play an important role 
in facilitating or suppressing the ability of the causative agent to cause 
diarrhoea. Thus, deficiency in colostral immunoglobulins in the newborn 
calves and piglets make them more susceptible to diarrhoea‚ and with a 
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high mortality rate‚ than animals with adequate levels. The stresses of 
transportation or deprivation of feed and water are commonly precipitate 
enteric salmonellosis. Also the stress of weaning in pigs is a risk factor 
for post weaning diarrhoea‚ while the prolonged orally use of 
antimicrobials in all species may alter the intestinal microflora and allow 
the development of a superinfection by organisms which would not 
normally cause disease. Blood et al., (1983) stated that over crowding of 
the dam and calf rearers are other epidemiological factors that caused 
diarrhoea in newborn calves. Woode and Dennis‚ (1978) found that 
calves born to heifers have higher incidence of the disease and are most 
seriously affected and hence high morbidity and mortality. A study of 
Woode and Crouch‚ (1978) found that, under experimental conditions‚ a 
drop of 10−20º C of the ambient temperature increased the mortality 
associated with enteric pathogens. 
          In North America, Babuik et al.‚ (1985) reported that the clinical 
disease is prevalent during the calving season in late winter or early 
spring while there is no evidence of infection for the other 8−10 months. 
Ferris (1971) also, reported that although coronavirus induced disease can 
occur through out the year‚ peak incidence occurs in early spring were 
calving is often concentrated. Prevalence studies have found that about 
70% of cryptosporidiosis cases occur also during winter (Anderson and 
Hall‚ 1985).      
          Babuik et al.‚ (1985) suggested that the two possible causes of 
emergence or disappearance of the disease are due to the virus which may 
persist in the environment protected by organic matter and the small 
number of adults that are persistently infected showing no clinical signs 
but shedding the virus, he concluded to that this stability of most enteric 
viruses in organic matter and large numbers of virus particles shed in 
faeces (10¹¹ rotavirus particles/g of faeces) ensures the environmental 
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contamination and infection. Rhodes et al.‚ (1979) showed that with 
electron microscopy‚ the virus can be detected for up to 6−10 days after 
the onset of diarrhoea.  
1. 5 Pathogenesis 
1. 5. 1 Mechanisms of diarrhoea   
          Under normal condition, a large quantity of fluid enters the small 
intestine from the saliva‚ stomach‚ pancreas‚ liver and intestinal mucosa. 
This fluid and its electrolytes and other nutrients must be absorbed mainly 
by the small intestine‚ although large quantities move into the large 
intestine for digestion and absorption, especially in the horse. Any 
dysfunction of the intestine will result in failure of adequate absorption 
and diarrhoea (Radostits et al.‚ 2000), depending on the causative agent, 
he concluded to that intestinal malabsorption may be the result of at least 
four different mechanisms: 
1. 5. 1. 1 Osmotic diarrhoea  
          There is an osmotic effect when substances within the lumen of the 
intestine increase the osmotic pressure over a greater than normal length 
of intestine‚ resulting in an osmotic movement of an excessive amount of 
fluid into the lumen of the intestine. The fluid is not reabsorbed and 
accumulates into the lumen. Saline purgatives‚ overfeeding‚ indigestible 
feeds and disaccharidase deficiencies are some of these substances.  
          The usual pathogenetic sequence of events is selective destruction 
of villous absorptive cells‚ villous atrophy, loss of digestive and 
absorptive capacities (malabsorption) ‚ diarrhoea‚ crept hyperplasia and 
recovery. Recovery depends on the severity of the lesion‚ the relative 
injury done to the villous cells and crept epithelium‚ and the age of the 
animal. It is postulated that the viral infection of the villous epithelial 
cells redirected cell function from absorption to virus production, and 
thus the digestive fluids and partially ingested milk accumulated in the 
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intestinal lumen (Mebus et al.‚ 1971; Mebus‚ 1976 and Woode and 
Crouch‚ 1978).  
          Pohlenz et al., (1978) reported that the pathogenesis of 
cryptosporidiosis is by pushing away the brush border of small intestine 
(lower part) and colon‚ which in turn decrease the intestinal enzyme 
activity. Because the organisms reside within the brush border of 
intestinal absorptive cells‚ the primary mechanism for diarrhoea appear to 
be malabsorption (Moore‚ 1989). Cryptosporidium oocysts exist within 
the lumen of the intestine leading to auto or self infection with the 
sporozoites. This ability of cryptosporidium allows individual animals to 
be infected persistently. Pohlenz et al., (1978) stated that the infection 
persisted for at least 10 months in one calf infected with 
cryptosporidiosis. 
1. 5. 1. 2 Exudative diarrhoea 
          Acute or chronic inflammation or necrosis of the intestinal mucosa 
caused by bacteria‚ viruses‚ fungi‚ protozoa‚ chemical agents and tumors 
results in both a net increase in fluid production and inflammatory 
products‚ including loss of serum proteins and a reduction in absorption 
of fluids and electrolytes. The classic example is enteric salmonellosis in 
which there is severe inflammation with the production of fibrinous‚ 
hemorrhagic enteritis. Mebus‚ (1976) stated that large population of 
bacteria in the intestinal lumen might also delay restoration of the 
intestinal epithelial or even cause further epithelial injury. Other notable 
examples include swine dysentery‚ bovine virus diarrhoea and inorganic 
arsenic poisoning. There is also evidence that active electrolyte secretion 
occurs in enterocolitis is due to salmonellosis in several species of 
animals. In diseases such as swine dysentery‚ the permeability of the 
colon may remain normal or even decrease‚ but the absorption of water 
and electrolytes is decreased. This suggests that the primary cause of fluid 
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and electrolyte loss in some diseases of the colon may be due to failure of 
the affected epithelium to absorb fluids and electrolytes (Radostits et al.‚ 
2000). 
          Stafseth‚ (1931); Ott‚ (1937) and Tyzzer‚ (1937) reported that in 
coccidiosis also there is severe destruction of intestinal lining epithelium 
and these may predispose to secondary bacterial infection by 
opportunistic pathogen. 
1. 5. 1. 3 Secretory diarrhoea  
          A secretory−absorptive imbalance results in a large net increase in 
fluid secretion with little if any structural change in the mucosal cells. 
The enterotoxins produced by enterotoxigenic E.coli cause an increase in 
net secretion of fluid and electrolytes from systemic circulation into the 
lumen of the intestine (Smith and Hall‚ 1967).   The villi‚ along with their 
digestive and absorptive capabilities‚ remain intact. The crypts also 
remain intact; however‚ their secretion is increased beyond the absorptive 
capacity of the intestines‚ resulting in diarrhoea. The increased secretion 
is due to an increase in cyclic adenosine monophosphate which in turns 
stimulated by prostaglandins.              
           It is diagnostically useful in enterotoxic colibacillosis when the 
integrity of the mucosal structure is maintained and the secreted fluid is 
isotonic‚ electrolyte rich‚ alkaline and free of exudates. The outcome is 
varying degrees of dehydration‚ electrolyte imbalances‚ acidosis‚ 
hyperkalemia and when acidosis is severe‚ circulatory failure‚ shock and 
death (Radostits et al.‚ 1994).Thus the presence of the histopathological 
changes such as villous atrophy and severe inflammation in the intestinal 
epithelium of calves and pigs infected with enterotoxigenic E. coli 
suggests that other substances such as endotoxins may be released from 
other strains of E. coli or from other enteropathogens (Hornich et al.‚ 
1975).  
 15
1. 5. 1. 4 Abnormal intestinal motility  
          Hyperexcitability‚ convulsions and the stress of unexpected sudden 
confinement may result in diarrhoea which may be due to increased 
peristalsis resulting in intestinal hurry and reduced intestinal absorption 
due to rapid passage of intestinal fluids in an otherwise normal intestine. 
This can occur in animals which are being assembled for transportation 
and during transportation (Radostits et al.‚ 2000). 
1. 6 Pathophysiologic changes 
1. 6. 1 Dehydration           
          The net effect of an increase in the total amount of fluid in the 
intestinal lumen and a reduction in intestinal absorption is a loss of fluids 
and electrolytes at the expence of body fluids and electrolytes and the 
normal intestinal juices. The fluid which is lost consists primarily of 
water‚ the electrolytes: sodium; chloride; potassium and bicarbonate‚ and 
varying quantities of protein. Protein is lost (protein losing enteropathy) 
in both acute and chronic inflammation leading to hypoprteinemia in 
some cases. The loss of bicarbonate results in metabolic acidosis which is 
of major importance in acute diarrhoea. The loss of sodium‚ chloride and 
potassium results in serum electrolyte imbalances. In the horse with 
enteric sallmonellosis‚ there is severe dehydration and marked 
hyponatremia. In the calf with neonatal diarrhoea there are varying 
degrees of dehydration and a moderate loss of all electrolytes. In acute 
severe diarrhoea‚ there is severe acidosis and reduced circulating blood 
volume. This results in uremia‚ anaerobic oxidation and lactic acidosis 
which accentuates the metabolic acidosis. Hyperventilation occurs in 
some animals in an attempt to compensate for the acidosis.  
          In acute diarrhoea‚ large quantities of intestinal fluid are lost in the 
faeces and large quantities are present in the intestinal lumen 
(intraluminal dehydration), which accounts for the remarkable clinical 
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dehydration in some affected animals. The fluid moves out of the 
intravascular compartment first, then out of the extravascular 
compartment (interstitial spaces)‚ followed lastly from intracellular space. 
Thus in acute diarrhoea of sudden onset the actual degree of dehydration 
present initially may be much more severe than is recognizable clinically; 
as the diarrhoea continues, the degree of clinical dehydration becomes 
much more evident.  
          In chronic enteritis, the intestinal wall becomes thickened and 
mucus secretion is stimulated, the absorption of the intestinal fluids is 
also decreased but not of the same magnitude as in acute enteritis. In 
chronic enteritis, also there is a negative nutrient balance because of 
decreased digestion of nutrients and decreased absorption resulting in 
body wasting (Mebus‚ 1976 and Radostits et al.‚ 2000). The animal may 
continue to drink and maintain almost normal hydration. In some cases of 
chronic enteritis, depending on the cause, there is continuous loss of 
protein leading to clinical hypoproteinemia. Intestinal helminthiasis of all 
species, John’s disease of ruminants and chronic diarrhoeas of the horse 
are examples. 
1. 6. 2 Acidosis  
          The loss of faecal bicarbonate leads to development of acidosis‚ 
Tenant et al.‚ (1972); Lewis et al.‚ (1973) and (1975) found that, acidosis 
also develops as a result of renal dysfunction, increased microbial activity 
in response to fermentation of undigested milk as well as increased 
production and decreased utilization of lactic acid in dehydrated calves.  
1. 7 Clinical findings  
          Dysentery‚ varying degrees of dehydration and acid base 
imbalance‚ abdominal pain‚ septicemia and toxaemia with fever occur 
commonly with diarrhoea which is the major clinical findings in enteritis 
or malabsorption, and their degree of severity depends on the causative 
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agent and its location, the age and species of animal‚ and the stage of the 
disease (Radostits et al.‚ 2000).  
          In acute diarrhoea‚ the faeces are soft or fluid in consistency and 
may have an unpleasant odor. They may contain blood (dysentery)‚ 
fibrinous casts and mucus or obvious foreign material such as sand. The 
colour of the faeces will vary considerably and usually not representative 
of a particular disease. However, viral infection is characterized by rapid 
onset of depression‚ anorexia and few strings of thick saliva hanging from 
the lips and then there is a sudden onset of profuse watery diarrhoea‚ 
faeces are pale yellow mucoid and may contain flecks of blood (Mebus, 
1976), while the syndrome in old ages group can be clinically severe and 
result in temporary physiologic disturbances as a marked decline in the 
milk production of cows during the first ten days of infection (woode and 
crouch‚ 1978; Fleetwood et al.‚ 1989; Durham et al.‚ 1989 and Benfield 
and Saif‚ 1990).  
          In chronic diarrhoea‚ the faeces are usually soft‚ homogeneous in 
consistency‚ contain considerable mucus and usually do not have a 
grossly abnormal odor. Progressive weight loss and emaciation are 
common and there are usually no systemic abnormalities. Animals with 
chronic diarrhoea will often drink and absorb sufficient water to maintain 
clinical hydration but there may be laboratory evidence of dehydration 
and electrolyte loss. 
          In parasitic infection and abomasitis there may be hypoproteinemia 
and subcutaneous edema. Weight loss‚ anorexia‚ depression‚ weakness 
and dehydration are also reported in cryptosporidiosis infection (Pohlenz‚ 
1980). 
          Rectal body temperatures are usually normal‚ they can be 
subnormal in severely ill animals in colibacillosis infection (Zeman et al.‚ 
1989). 
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1. 8 Clinical Pathology 
          The approach to the diagnosis of diarrhoea requires a consideration 
of the epidemiological history and the nature and severity of the clinical 
findings. With the exception of the acute diarrhoea in newborn farm 
animals, most of the other common enteritis have reasonably distinct 
epidemiological and clinical features. However, the accurate and specific 
etiological diagnosis of infectious diarrhoeic disease is difficult to obtain. 
Some reasons of this difficulty are the variety of the incriminated agents, 
the non specific symptoms manifested and the environmental factors 
(Logan‚ 1974 and Acres‚ 1975). Schoenian, (2009) stated that it is not 
possible to definitively determine the infectious organism by looking at 
the colour‚ consistency‚ or odor of the faeces. A definitive identification 
requires a sample for microbiological analysis. Thus, Examination of the 
faeces is to determine the presence of causative bacteria‚ helminths‚ 
protozoa‚ viruses and chemical agents and to differentiate them depends 
on laboratory examination and also, to determine the presence or absence 
of blood. 
          In outbreaks of diarrhoea‚ especially in neonates, it may be useful 
to do necropsies on selected early untreated cases of acute diarrhoea.  
Faecal samples should be taken from both normal and affected animals 
because the comparison of results will improve the accuracy of 
interpretation. 
          If possible, a heamogram should be obtained to assist in 
determining the presence or absence of infection.  
1. 9 Treatment 
         Principles of treatment of enteritis and the consequent diarrhoea are: 
1. 9. 1 Removal of the causative agent  
          Specific treatment is usually directed at intestinal helminthiasis 
with anthelmintics‚ antiprotozoan agents against disease like coccidiosis 
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and antimicrobials agents against the bacterial infections. There are no 
specific treatments available for the viral diarrhoea in farm animals 
(Radostits et al.‚ 2000). However, in the absence of complication, 
recovery from viral infection will occur without specific treatment (Blood 
et al.‚ 1983). Also for cryptosporidiosis, no effective treatment is known 
however, supportive therapy containing energy sources is the best means 
of minimizing starvation and mortality (Moore‚ 1989).   
1. 9. 1. 1 Antimicrobials 
          The use of antimicrobials either orally or parenterally‚ or by both 
routes simultaneously for the treatment of the possible presence or 
occurrence of enteric or systemic bacterial infections is a controversial 
subject in both human and veterinary medicine. Parenteral preparations 
are indicated in animals with acute diarrhoea‚ toxemia and fever to avoid 
death. Many antimicrobials when given parenterally‚ are excreted by the 
liver into the lumen of the intestine and oral preparations may not be 
necessary. In cases of sub-acute diarrhoea with minimal systemic effects‚ 
the use of an oral preparation may be sufficient. However‚ oral 
perpetrations should not be used more than three days to avoid 
suprainfection and because their use allows the development of multiple 
drug resistance‚ which is a major public health concern (Radostits et al.‚ 
2000). 
          Studies of Baljer‚ (1986) showed that some bacterial strains are 
resistant to most antibiotics, so that antibiotic therapy is unlikely to 
succeed unless the sensitivity to the bacteria was tested before treatment. 
Jones‚ (1996) also reported that the wide spread and erratic use of broad 
spectrum antibiotics without proper isolation of the causative agent and 
drug sensitivity test is a real cause of resistance. McDonnell and Russel‚ 
(1999) and Russel‚ (1999) concluded that, different types of microbes 
vary in their response to antibiotics and other antimicrobial agents. 
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However, uses of antibiotics in selected cases of diarrhoea will decrease 
the symptoms or reduce faecal shedding of the organism and prevent 
spread of infection. While wrong choice of antimicrobial agents will 
worsen the symptoms. It may increase the length of time over which 
affected animals excrete the organisms which may occur in enteric 
salmonellosis. Thus, risk and benefits should be considered before 
prescribing antimicrobial agents (Lolekha‚ 1986).  
          However, time does not usually permit pretreatment culture of the 
organism and determination of the drug sensitivity‚ so that the broad 
spectrum antibiotics and selected chemotherapeutics based on previously 
successful experience are used (Blood et al.‚ 1983).  
          Mass medication of the drinking water supply with antimicrobials 
for the treatment of outbreaks of specific infectious enteritis in animals is 
used commonly and with success. One of the best examples is pigs 
affected with swine dysentery. However, not all animals will drink 
sufficient quantity of medicated water and daily intake must be monitored 
carefully. Severely affected animals in an outbreak need individual 
treatment (Radostits et al.‚ 2000).  
1. 9. 2 Alteration of the diet 
If the cause of the diarrhoea is dietary in origin, the feed should be 
removed until the animal has fully recovered; feed should then be 
replaced by another source or reintroduced gradually when recovery is 
apparent. The rationale is that, in acute enteritis the digestibility of 
nutrients is reduced considerably and undigested feed provides a substrate 
for fermentation and putrefaction to occur‚ the products of it accentuate 
the malabsorptive state. Blood et al. ‚ (1983) also stated that‚ it would 
appear logical not to feed the calf with nutrients such as milk which must 
be digested but rather to provide readily absorbable substances such as 
oral glucose and electrolyte mixture.  
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However, temporary withdrawal of feed presents practical 
problems especially in the youngs. The temporary removal from the sow 
of new born piglets affected with acute enteritis presents practical 
problems and is of doubtful value; similarly with beef calves nursing 
cows on pasture. With foals it is relatively easy to muzzle them for 24 
hours. With weaned piglets affected with weanling diarrhoea and feeder 
pigs with swine dysentery‚ it is common practice to reduce the normal 
daily intake by half for a few days until recovery is apparent, while 
mature horses affected with diarrhoea should not have access to any feed 
for at least 24 hours (Radostits et al. ‚ 2000), and even in diarrhoeic 
calves which are being hand fed milk replacer or whole milk it is 
common beneficial practice to starve for 24―48 hours (Blood et al. ‚ 
1983).  
During the period of temporary starvation‚ the oral intake of fluids 
containing glucose and electrolytes is desirable and necessary to assist in 
maintaining hydration. In newborn calves with diarrhoea‚ if oral fluid 
intake is maintained‚ the total loss of water from faeces and through the 
kidney is not significantly greater than in normal calves because in 
diarrhoeic calves the kidney will effectively compensate for faecal losses. 
1. 9. 3 Fluids and electrolytes   
The initial goals of fluid and electrolyte therapy for the effects of 
diarrhoea are: the restoration of the body fluids to normal volume‚ 
effective osmolality, composition and acid−base balance. The quality and 
quantity of fluids required to achieve these goals depend on the 
characteristics of the dehydration and acid−base electrolyte imbalance. 
Fluids should be given orally whenever possible to save time and expense 
and to avoid the complications which can arise from longterm parenteral 
fluid therapy. Also‚ fluids should be given as early as possible to 
minimize the degree of dehydration. 
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The three major abnormalities of dehydration‚ acidosis and 
electrolyte deficit are usually corrected simultaneously with fluid therapy. 
When severe acidosis is suspected‚ this could be corrected immediately 
with a hypertonic (5%) solution of bicarbonate given I/V followed by the 
administration of electrolyte solution in quantities necessary to correct the 
dehydration because in severe dehydration‚ equivalent to 10% of BW was 
losted‚ hence large amounts of fluids are necessary. 
 The initial hydration therapy should be given over the first 4−6 
hours by continuous intravenous infusion, followed by maintenance 
therapy for the next 20−24 hours, or for the duration of the diarrhoea if 
severe. Radostits et al., (2000) reported that Horses with acute enteritis 
have severe hyponatremia, and following fluid therapy may become 
severely hypokalemic, as evidenced by weakness and muscular tremors. 
The hypertonic solution of sodium bicarbonate will assist in correcting 
the hyponatremia but potassium chloride may need to be added to large 
quantity of fluids given for dehydration; 1 g of potassium chloride added 
to each liter of fluid will provide an additional 14 mosmol/L (14 mmol/L) 
of potassium. In preruminant calves with diarrhoea‚ the total daily 
requirement is divided into equal doses given every two to four hours 
(Zeman et al. ‚1989). 
  In the early stage of acute diarrhoea and for animals which are not 
severely dehydrated‚ the oral route can also be used successfully to 
correct dehydration and prevent it from becoming worse. Piglets and 
lambs affected with dehydration are most effectively using balanced 
electrolyte solutions given S/C at a dose rates of 20 mL/kg BW every 4 
hours and orally at 20 mL/kg BW every 2 hours. Mebus‚ (1976) reported 
that a simple effective solution for parenteral use is an equal mixture of 
isotonic saline (0.85%), isotonic dextrose (5%) and isotonic sodium 
bicarbonate (1.3%).  
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1. 9. 4 Intestinal protectants and absorbent 
          According to Radostits et al., (2000), Kaolin and pectin mixture are 
used widely to coat the intestinal mucosa‚ inhibit secretions and increase 
the bulk of the faeces in animals with enteritis, while Aiello and Mays‚ 
(1998) stated that although kaolin− pectin is claimed to act as demulcent 
and adsorbent in the treatment of diarrhoea‚ clinical studies have not 
demonstrated any benefits from its administration.  
1. 9. 5 Anti-diarrhoeal drugs 
     Anti-diarrhoeal drugs are medicines that relieve and help to control 
diarrhoea and some of the symptoms that go along with it.  
1. 9. 5. 1 Antimotility drugs 
          Anticholinergic drugs and opiates are available to decrease 
intestinal motility. The anticholinergic drugs block the action of 
acetylcholine on smooth muscle and glands. This results in decreased 
gastric secretion and emptying and a reduction on both segmental and 
propulsive movements of the intestines. The opiates function by 
producing an increase in segmentation while reducing propulsive 
movements in the intestine. The net effect is an increase in resistance to 
passage of intestinal contents and more complete absorption of both water 
and nutrients occurs with a subsequent decrease in the frequency of 
defecation (Radostits et al. ‚ 2000). He also stated that there are no 
reports of clinical trials using antimotality drugs for the treatment of 
diarrhoea.     
1. 9. 5. 2 Antisecretory drugs   
Antisecretory drugs are also available for the treatment of diarrhoea 
due to the hypersecretory activity of enterotoxin produced by bacteria 
such as enterotoxigenic E. coli.  
Loperamide hydrochloride given orally to calves with 
experimentally induced diarrhoea can delay the onset of diarrhoea by its 
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inhibition of fluid secretion (Radostits et al. ‚ 2000). Blood et al. ‚ (1983) 
reported that antiparasympathomimetics also include chlorpromazine 
which is antagonistic to enterotoxin cell system and acetylsalsalic acid 
which reduces fluid accumulation while other antisecretory drugs 
include‚ opiates‚ atropine‚ prostaglandin inhibitors have not been yet 
adequately evaluated and the provision of balanced fluids and 
electrolytes‚ containing sodium chloride‚ sodium bicarbonate‚ potassium 
chloride and glucose‚ given both parentally and orally‚ are considered to 
be adequate and effective for treating the effects of the hypersecretion 
(Radostits et al. ‚ 2000).  
1.10 Control 
The control and prevention of enteritis in farm animals is a major 
topic and activity of large animal practice. Because of the complex nature 
of disease‚ it is unrealistic to expect total prevention and control at 
economical level should be a major goal.  
          However, Radostits et al. ‚ (2000) concluded to that the principles 
of control include the following:  
• Reduce infection pressure by controlling population density.  
• Ensure adequate non−specific resistance by adequate 
colostrum intake of neonatal farm animals and maintaining adequate 
nutritional status. Worth to notice that protection against enteropathogens 
depends upon the antibodies within the lumen of the digestive system 
thus the colostrum must contain reasonably higher level of antibodies and 
it must be fed every day during crucial age period of susceptibility to be 
effective (Blood et al. ‚ 1983 and Sanders‚ 1985). McBeath‚ (1971) found 
that multiple small intakes of colostrums give significantly a greater level 
of immunoglobulins than single large intake. Saif and Smith, (1983) 
suggested that subclinical infection of neonates with rotavirus may occur 
at birth or shortly thereafter as long as adequate levels of colostral‚ milk 
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or serum antibodies persist. Colostrum provides protection against 
colisepticaemia in calves but does not prevent diarrhoea (Logan‚ 1973). 
However‚ feeding immune colostrum can delay onset of diarrhoea‚ 
reduce its incidence‚ duration and severity and consequently improve live 
weight (Snodgrass et al. ‚ 1982). Evidences available which suggest that 
rotavirus antibody in milk can protect against small challenge dose and 
maternal immunization against rotavirus may be a practical proposition 
(Snodgrass et al. ‚ 1980). Saif and Smith‚ (1983) also‚ stated that daily 
feeding (two times/ day) of as little as 40 ml (total) of high tittered 
colostrum to calves completely protected them against diarrhoea and 
rotavirus shedding when challenged.  
Bachmann, (1982) reported that high serum antibody levels can 
provide some protection through the leakage back into the intestine while 
Snodgrass and Wells (1978a) studied the effect of serum on the course of 
rotaviral infections to lambs; they found that serum or serum products of 
high antibody titers against rotavirus could replace colostrum if it’s not 
available. The duration of the immunity is not known (Blood et al. 
‚1983). Thus as immunity may be only partial and not long lasting‚ adults 
may be diseased from infected neonates‚ two cows with severe diarrhoea 
whose calves had calf scours‚ were shown to be infected with rotavirus 
indicating that there is no age resistance for rotavirus enteritis in cattle 
breed (Woode and Bridger‚ 1975). 
Serum antibodies offer a comparable model for antibodies in 
colostrum‚ it is also possible that serum or serum products may 
themselves be a feasible method for rotaviral prophylaxis or therapy. 
Hyper-immune serum intraperitoneally or orally may be providing a 
method for protecting neonatal calves against rotaviral diarrhoea (100% 
protection) (Wells et al. ‚ 1978). 
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•      Vaccinate for those diseases for which there is an effective 
vaccine. The ultimate impact of vaccines on animal’s production will 
depend on their cost effectiveness as compared to the alternate means of 
control. Active or passive immunizations are both used as vaccine 
programmes against neonatal calf diarrhoea. 
Parental vaccination of the pregnant dam before parturition may 
increase the level and the duration of colostral vaccine immunity 
(Snodgrass and Wells‚ 1978b; Snodgrass‚ 1984). Baljer (1986) and 
Castrucci et al. ‚ (1987) in a field trial reported that morbidity and 
mortality rates of neonatal diarrhoea of calves‚ after introduction of 
maternal immunization‚ had been significantly decreased in those 
received colostrums from vaccinated dams. Trials have also been made to 
actively immunization either by parental injection of vaccine or orally. 
Oral vaccines for calves against rotavirus and coronavirus are available 
but their efficiency has been debated (Deleeuw‚ 1980; Walter−Toews et 
al.‚ 1985) ‚ by contrast good results had been obtained from active oral 
immunization of newborn calves with heat inactivated enterotoxigenic E. 
coli (Baljer‚ 1986). Rotavirus neutralizing antibody was associated with 
IgG in both colostrum and milk suggesting that vaccination of the dam 
may be of value in protecting the suckled lamb against rotavirus infection 
(Wells et al.‚ 1978). Snodgrass and Wells (1978a) studied the effect of 
serum on the course of rotaviral infections to lambs; he found that serum 
or serum products of high antibody titers against rotavirus could replace 
colostrum if it’s not available. 
Serum antibodies offer a comparable model for antibodies in 
colostrum‚ and it is also possible that serum or serum products may 
themselves be a feasible method for rotaviral prophylaxis or therapy. 
Hyper−immune serum intraperitoneally or orally may be providing a 
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method for protecting neonatal calves against rotaviral diarrhoea (100% 
protection) (Wells et al. ‚ 1978). 
The prognosis of E. coli infections is unfavorable if the level of 
immunoglobulins is low regardless of intensive fluid and antimicrobial 
therapy (Blood et al. ‚1983). Vaccination is coming into routine use as 
part of programmes to control ETEC infections in farm animals in U.S.A. 
Most of the field trials that have been reported‚ have presented evidence 
that vaccination can reduce morbidity and mortality due to naturally 
occurring ETEC infection. Under some regimes‚ protection of suckling 
can be enhanced if dams are vaccinated orally than parentaraly (Collin, 
1974). 
Nonliving vaccine contain components to stimulate both anti 
bacterial and antitoxic immunity were added to animal feed. Multiple oral 
doses from nonliving vaccine are required to prime the secretory immune 
system and assure a good local antibody response. 
Vaccination in-utero was used to induce active immunity in calves‚ 
but this method is totally impractical under field conditions (Newman et 
al. ‚ 1978).   
• Minimize managemental and environmental stressors. 
Mebus‚ (1976) stated that introduction of new animals of any age shortly 
before or during calving should be discouraged. Janke‚ (1989) found that 
identification and removal of persistently infected carrier animals is a 
priority in control of viral enteritis.  
Suckling calves survived better than fed calves because they do not 
acquire the same high levels of serum immunoglobulins, however‚ in 
both cases the presence of the dam improves the absorption (Umoh, 1982 
and Blood‚ et al.‚ 1983).     
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• Monitor morbidity and mortality and ensure that a diagnosis 
is obtained so that control measures for newly introduced diseases into a 
herd can be instituted.  
1. 11 Plants with anti-diarrhoeal effects 
          Atta and Mouneir, (2004) found that oral administration of 
methanolic extracts of six Egyptian medicinal plants from Conyza 
dioscoridis (CD), Alhagi maurorum (AM), Mentha microphylla (MM), 
Zygophyllum album (ZA), and Conyza linifolia (CL) exhibited a 
significant (P<0.01) anti-diarrhoeal effect against castor oil-induced 
diarrhoea at different doses, 200 and 400mg/kg while Convolvulus 
arvensis (CA) produced no anti-diarrhoeal effect in rats at all doses. 
          The anti-diarrhoeal activity of Hypoxis hemerocallidea corm 
aqueous extract (APE) which is known as ( African potato ) was 
investigated on experimentally-induced diarrhoea in rodents at doses, 50 
and 400 mg/kg, given orally and produced a dose-dependent and 
significant (p < 0.05-0.01) protection of rats and mice against castor oil-
induced diarrhoea, inhibited intestinal transit and delayed gastric 
emptying. This finding supports the use of African potato  as a natural 
supplementary remedy for the treatment, management and/or control of 
diarrhoea in some rural communities of southern Africa (Ojewole et al., 
2008). 
         Agbor et al., (2003) reported that Alchornea cordifolia which is 
quoted by many traditional healers in Cameroon as a plant with anti-
diarrhoeal activity, its leaf extract was investigated against castor oil 
induced diarrhoea in mice at doses 100, 200, 400 and 800 mg/kg, using 
morphine as the standard reference drug. A significant (p < 0.01) dose 
inhibited the production of diarrhoeal faeces, was observed with 800 
mg/kg, being the most effective. Phytochemical screening revealed the 
presence of tannins and flavonoids which may account for the increased 
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colonic water and electrolyte reabsorption, a mechanism suggested for the 
anti-diarrhoeal activity of A. cordifolia.  
          Ethnobotanical studies indicate that Helianthemum glomeratum is a 
plant widely used in Maya communities to treat diarrhoeas (Meckes et al., 
1996). 
          Anti-diarrhoeal activity of Sclerocarya birrea bark extract and its 
active tannin constituent in rats was investigated by Galvez et al., (1991), 
the lyophilized decoction demonstrated anti-diarrhoeal activity in 
experimental models of diarrhoea induced by magnesium sulphate and 
sodium picosulphate. Condensed tannin was isolated from the crude drug 
which produced inhibition in intestinal motility, and the monomer of 
which was identified as procyanidin. 
          Shah et al., (2009), reported that in an in vivo study the crude 
extract of Alstonia scholaris (As.Cr), which tested positive for the 
presence of alkaloids, provided 31-84% protection against castor oil-
induced diarrhoea in mice at 100 and 1000 mg/kg doses, similar to 
loperamide. 
          Studies of Akah et al., (1998) have demonstrated a potential anti-
diarrhoeal activity of the aqueous (WE) and ethanol (EE) leaf extracts of 
Pentaclethra macrophylla using experimental animal models. Anti-
diarrhoeal of the extracts was evidenced by a significant reduction in 
faecal output and protection from castor oil-induced diarrhoea in rats 
treated with the extracts. The antispasmodic as well as the antimicrobial 
effects of the extracts possessed, may explain the rationale for the use of 
the plant in traditional medicine as a popular anti-diarrhoeal recipe.  
          Murugesan et al., (1999) evaluated the anti-diarrhoeal profile of a 
methanol extract of the aerial parts of Jussiaea suffruticosa Linn. with 
several experimental models of diarrhoea in rats. The extract exhibited 
significant anti-diarrhoeal potential at doses of 100, 200 and 300 mg/kg in 
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all the animal models and thus established the efficacy of MEJS as a 
potent anti-diarrhoeal agent. 
          Seven plants extracts namely: the aerial parts of Euphorbia 
paralias L. (EP), Bidens bipinnata L. (BB), Cynachum acutum L. 
(CyAc), Diplotaxis acris (Forssk.) Boiss (DA), Convolvulus fatmensis 
(CF) and Schouwia thebaica Webb (ST) and the leaves of Plantago major 
L. (PM) were evaluated for their anti-diarrhoeal effects on castor oil-
induced diarrhoea. A significant anti-diarrhoeal effect of the tested plant 
extracts against castor oil-induced diarrhoea in rats was achieved by 200 
and 400 mg/kg. Tannins, flavonoids, unsaturated sterols/triterpenes, 
carboy-rates, lactones and proteins/amino acids were reported as major 
active constituents of the tested plants (Atta and Mouneir, 2004). 
          Studies were carried out on castor oil-induced diarrhoea in mice to 
evaluate the anti-diarrhoeal effect of the aqueous root extract of 
Terminalia avicennoides in rodents. The results revealed that the extract 
(100, 200 and 400 mg/kg) markedly protected mice against castor oil-
induced diarrhoea. A preliminary phytochemical screening of the aqueous 
extract of T. avicennoides roots revealed the presence of tannins, saponins 
and flavonoids. The results obtained showed that the water extract of T. 
avicennoides roots may contain some biologically active principles that 
may be active against diarrhoea and this may be the basis for its use 
traditionally for gastrointestinal disorders (Abdullahi et al., 2001).  
          Besra et al., (2000) found that the aqueous methanol extract of 
Albizzia lebbeck seeds (2.5 and 5 mg/kg i.p.) possessed anti-diarrhoeal 
activity against castor oil-induced diarrhoea in rodents, which strengthens 
the earlier use of the seeds in the treatment of diarrhoea and dysentery. 
          The anti-diarrhoeal activity of a procyanidin isolated from the bark 
of Sclerocarya birrea was studied, using four models of experimentally 
induced diarrhoea in rats. The cathartic agents used were: magnesium 
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sulphate, castor oil, arachidonic acid and prostaglandin E2. At doses of 
150 mg/kg, the procyanidin showed anti-diarrhoeal activity in all the 
models of experimentally induced diarrhoea (Galvez et al., 1992). 
          The bark of Myracrodruon urundeuva (family Anacardiaceae), 
which is used in popular medicine as an anti-diarrhoeal agent, has been 
investigated for its effects on castor oil-induced diarrhoea. In rats, the 
ethanol extract of stem bark significantly inhibited the castor oil-induced 
diarrhoea, at an oral dose of 400 mg/kg (Chaves et al., 1998). 
          Kumar et al., (2001) reported that indigenous Indian plants such as 
Andrographalis paniculata, Asparagus racemosus, Butea monosperma, 
Cassia auriculata, Ficus hispida, Hemidesmus indicus and Guiera 
senegalensi are widely used to treat diarrhoea. 
1. 12 Plant used in the present study 
1. 12. 1 Hydnora abyssinica A. Braun ex Schweinf. : Figure (1)   
          Hydnora abyssinica A. Br. (family Hydnoraceace) is the accepted 
name in African Plant Checklist and Database. 
 Beentje and Luke, (2002) reported that there were 13 synonymy: 
• Hydnora johannis Becc. [family Hydnoraceae]  
• Hydnora cornii Vacc. [family Hydnoraceae]  
• Hydnora michaelis Peter [family Hydnoraceae]  
• Hydnora abyssinica A.Braun var. quinquefida Engl. [family 
Hydnoraceae]   
• Hydnora bogosensis Becc. [family Hydnoraceae]  
• Hydnora aethiopica Decne. [family Hydnoraceae]  
• Hydnora johannis Becc. forma forma trimera Vacc. [family     
Hydnoraceae]  
• Hydnora ruspolii Chiov. [family Hydnoraceae]  
• Hydnora johannis forma forma gigantea Becc. [family Hydnoraceae]  
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               (Un- opened flower) 
 
               (Un- opened flower broken by animal) Tarangire, Tanzania 
             Fig. (1): Hydnora abyssinica     
                These photos belongs to kibuyu's photo stream (2,155) . 
              December 2009 in Babati, Manyara, TZ 
              http://www.flickr.com/photos 
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Fig. (2): Hydnora abyssinica A. Braun ex Schweinf 
                Opened flower 
                                Photo: Cathy Sharp  
                                            Nr Mvuma 
www.zimbabweflora.co.zw/speciesdata/species. 
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         Fig.(3): Hydnora abyssinica Schweinf. 
        275 × 585 - 7k – gif 
       www. puka.cs.waikato.ac.nz  
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• Hydnora hanningtonii Rendle [family Hydnoraceae]  
• Hydnora gigantea Chiov. [family Hydnoraceae]  
• Hydnora johannis Becc. var. quinquefida (Engl.) Solms [family 
Hydnoraceae]  
• Hydnora solmsiana Dinter [family Hydnoraceae] 
1. 12. 2 Derivaion of specific name 
          Abyssinica of Abyssinia (Ethiopia) (Hyde and Wursten, 2010). 
1.12. 3 Repository  
          Royal Botanic Gardens, Kew (K) (Beentje and Luke, 2002). 
1. 12. 4 Collections  
          Flora of Tropical East Africa (Beentje and Luke, 2002). 
1. 12. 5 Distribution and Vernacular name 
          Kenya, Tanzania, Uganda, Botswana, Zimbabwe, Ethiopia, 
Somalia, South Africa, Sudan, Swaziland, Tanzania, Uganda, Yemen, the 
Democratic Republic of  Congo, Namibia, Namibia, Rwanda and Eritrea 
(Beentje and Luke, 2002). 
Distribution in Sudan: Central Sudan and locally known as Tartous.  
1. 12. 6 Habitat 
          In Acacia woodland and scrub, Acacia-Commiphora scrub and 
grassland with scattered Acacia spp., usually on black cotton, clay and 
sandy alluvial soils, also on rocky slopes. Parasitic on Acacia spp. but 
also reported on Albizia, Delonix and probably Commiphora spp. 
(Musselman, 1997).    
1. 12. 7 Description 
          A Subterranean root parasite, lacking chlorophyll. Plant body 
(‘branch’) rhizome-like, simple or with widely spreading horizontal 
branches, fleshy, irregularly shaped, somewhat flattened, brown outside, 
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brick-red or reddish pink to white inside, with sticky, astringent exudates 
when fresh, rich in tannins. Flowers emerging directly from the main and 
side branches, remaining partially below ground and partially emerging, 
solitary or in groups, but only one per branch emergence point , with very 
foetid smell; pedicel absent. Perianth fleshy-coriaceous, Fruit entirely 
subterranean, fleshy, globose, many-seeded, often splitting irregularly at 
maturity; outer periderm scaly; inner pericarp mealy, white; seeds brown, 
oblong to globos. Seedlings are unknown. Plants usually flower after the 
onset of the rains. Flowers are extremely fetid, visited by beetles. Fruits 
develop about five months after the flowers appear, are scaly brown and 
entirely subterranean.  The species mostly parasitizes Acacia spp. Plants 
may be more common than recorded, as they are only visible when 
flowering (Musselman, 1997).    
1. 12. 8 Traditional uses   
          Fruits are sweet tasting and eaten by animals and people, with 
white flesh and abundant brown seeds. Other parts of the plant are eaten 
by animals (Hyde and Wursten, 2010). 
1. 12. 8 Medicinal uses  
     Roots are used as medicine for diarrhoea and to staunch 
hemorrhaging (Hyde and Wursten, 2010). 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2. 1 Materials and experimental designs 
Two experiments were performed in the testing plant material 
using rats.  
2. 1. 1 Anti-diarrhoeal activity of Hydnora abyssinica aqueous extract 
on rats 
2. 1. 1. 1 Plant material 
          The collected Hydnora abyssinica roots were identified and 
authenticated in the Department of Botany, Faculty of Science, University 
of Khartoum. 
2. 1. 1. 2 Animals, housing and management 
          Twenty four Wister white (Albino) rats of either sex weighing 
100−150gm were obtained from the Animals House Unit of the 
Medicinal and Aromatic Plants Research Institute (MAPRI), National 
Center for Research Khartoum, Sudan, where they were housed in cages 
(each of dimensions 12×12×12cm. accommodating one dose–group) and 
maintained in a room under standard environmental conditions 
(controlled temperature (22±2ºC) and relative humidity (60%)) with free 
access to water and formula rat feed (2.5 Mcal and 20% crude protein). 
          Animals were apparently healthy and they were identified by 
colour tail marks. One week was allowed as a preliminary adaptive 
period. 
2. 1. 1. 3 Administration and doses 
          At the end of the adaptation period, rats were divided randomly to 
five groups each of five rats. They were fasted for 18 hours with free 
access to water prior to the commencement of the experiment. All 
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groups’ individuals were given 1 ml/kg body wt. /rat caster oil orally 
using orogastric canulla as an acute diarrhoeal inducer 30 minutes 
subsequent to extract administration. Group1 rats were the un-treated 
control and received orally 1ml/kg body wt. /rat normal saline. Hydnora 
abyssinica roots aqueous extract was redissolved in distilled water and 
given orally to rats of Group 2 at 100 mg/kg body wt., 200 mg/kg body 
wt. to rats of Group 3 and 400 mg/kg body wt. to rats of Group 4, while 
rats in Group 5 were treated with Loperamide (Hikma Pharmaceutical, 
Amman, Jordan), 3 mg/kg body wt. /rat, p.o, as a reference anti-
diarrhoeal compound. Each rat was then housed separately in a cage over 
clean filter paper. Then diarrhoea episodes were observed for a period of 
24 hours. 
2. 1. 1. 4 Parameters  
          Clinical signs and mortality rates were recorded. First defecation 
time and frequency of defecation were also recorded. Total weight of 
faecal mass was collected successively and weighed at 4 and 6 hours post 
administration of castor oil. Anti-diarrhoeal activity was determined in 
terms of percentage reduction in cumulative faecal mass with respect to 
un-treated control group (Patel et al., 2006).  
          Blood samples were obtained from the ocular vein after the start of 
experimental dosing and thereafter 24 hours at slaughter with and without 
anticoagulant for haematological investigations and serum analysis 
respectively. Haemoglobin concentration (Hb), packed cell volume 
(PCV) and red blood cells (RBCs) counts were estimated. Mean 
corpuscular volume (MCV) and mean corpuscular Haemoglobin 
concentration (MCHC) were calculated.  
          Sera were analyzed for the concentration of total protein, albumin, 
sodium, potassium and calcium. 
 
 39
2. 1. 2 Toxicity of Hydnora abyssinica aqueous extract to Albino rats 
2. 1. 2. 1 Plant material 
          Hydnora abyssinica roots after collection were identified and 
authenticated in the Department of Botany, Faculty of Science, University 
of Khartoum. 
2. 1. 2. 2 Animals, housing and management 
          Twenty Wister white (Albino) rats of either sex weighing 100-130 
gm were obtained from the Animals House Unit of the Medicinal and 
Aromatic Plants Research Institute, National Center for Research 
Khartoum, Sudan, where they were housed in cages (each of dimensions 
12×12×12cm. accommodating one dose-group) and maintained in a room 
under standard environmental conditions (controlled temperature 
(22±2ºC) and relative humidity (60%)) with water provided ad libitum 
and formula rat feed (2.5 Mcal and 20% crude protein). Animals were 
apparently healthy and they were identified by colour tail marks. 
Experimental animals were allowed one week as a preliminary adaptive 
period. 
2. 1. 2. 3 Administration and dose rates 
          Post adaptive period, the animals were allotted randomly to four 
groups, each of five rats. Rats in Group 1 were the un-dosed control. 
Hydnora abyssinica aqueous extract was redissolved in distilled water 
and given orally (p.o) in daily doses at 400 mg/kg body wt. /rat to Group 
2. Rats in Group 3 received 800 mg/kg body wt./rat/day, while rats in 
Group 4 received 1600 mg/kg body wt./rat/day. Dosing continued for 
seven days. 
2. 1. 2. 4 Parameters 
          Clinical signs and state of living were recorded. The animals were 
observed for deaths and manifestation of toxic effects which include: 
agility, muscular tremors and convulsions. Breathing patterns, water and 
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food intake are also noticed. Blood samples were obtained from the 
orbital plexus with and without anticoagulant before the start of the 
experimental dosing and at slaughter for haematological examination and 
serum analysis. Haemoglobin concentration (Hb), packed cell volume 
(PCV) and red blood cells (RBCs) counts were measured. Mean 
corpuscular volume (MCV) and mean corpuscular haemoglobin 
concentration (MCHC) were also calculated.  
          Sera were analyzed for the activities of (AST), (ALT) and also for 
the concentration of metabolic indicators such as total protein, albumin, 
sodium and potassium. Rats were anaesthetized with diethyl ether and 
sacrified at the end of the week. Tissues were examined immediately to 
identify lesions.  
2. 2 Methods 
2. 2. 1 Preparation of the plant extract 
          Hydnora abyssinica roots were cleaned; shade dried and pulverized 
using pestle and mortar. A total of 500g coarse powder of the plant 
material obtained was successively extracted at the Medicinal and 
Aromatic Plants Institute (MAPRI), by soaking into boiling distilled 
water and left for 4 hours at room temperature, the mixture was 
occasionally shaken then filtered and the filtrates were cooled over night 
at −4ºC and concentrated. The concentrated extract was then freeze dried 
(Komolafe et al., 1988). The extract obtained was glittery powder, brown 
greenish in colour and weighed 70gm, the yield percentage was 
calculated. Then the extract obtained was stored in a closed container till 
use.   
2. 2. 2 Haematological methods 
          These were described by Schalm (1965). Blood samples from rats 
were collected into clean dry bottles containing the anti-coagulant heparin 
from the ocular veins. 
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2. 2. 2. 1 Haemoglobin (Hb) concentration 
          The concentration of haemoglobin was determined by the 
methaemoglobin technique. The method is based on the conversion of 
haemoglobin by Drabkins solution (0.2g of potassium cyanide, 0.2g of 
potassium ferricyanide and 1g of sodium bicarbonate per liter of distilled 
water) to cyanomethaemoglobin. The haemoglobin concentration was 
estimated in g/dl of blood. 
2. 2. 2. 2 Packed Cell Volume (PCV) 
          Fresh blood samples were drawn in capillary tubes and centrifuged 
in a microhaematocrit centrifuge (Hawksley and Sons Ltd. England) for 5 
minutes. Packed Cell Volume percent was read off on the scaling 
instrument provided with the centrifuge. 
2. 2. 2. 3 Red Blood Cells (RBCs) counts 
          Red blood cells were counted using an improved Neubauer 
haemocytometer (Hawksley and Sons Ltd. England). Formal citrate was 
used as a diluent. 
2. 2. 2. 4 Mean Corpuscular Volume (MCV) 
          The MCV was calculated from the PCV and RBCs values as 
follows: 
            10
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2. 2. 2. 5 Mean Corpuscular Haemoglobin Concentration (MCHC) 
          MCHC was calculated from Hb and PCV values as follows: 
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2. 2. 3 Chemical methods 
          Blood samples obtained, initially and a week thereafter, from the 
ocular vein of rats on dosing with the test extract were used to prepare 
sera for the chemical methods. Venous blood samples were allowed to 
clot. Serum was separated by centrifugation at 3000 r.p.m. for 5 minutes 
and stored at -20ºC until analyzed. Spectrophotometer, Merck Mega, 
Version 0.6, 1995 (E. Merck, Darmstadt, Germany) was used to analyze 
serum activities of enzymes AST and ALT and serum metabolites; total 
protein, albumin, sodium, potassium and calcium. 
2. 2. 3. 1 Total protein  
          Total serum protein concentration was measured by a colourimetric 
method using a commercial kit (Randox Laboratories Ltd., U.K.).  
Test principle 
          Colourimetric determination of total protein in serum is based on 
the Biuret reaction. The serum protein reacts with copper sulphate in the 
presence of sodium hydroxide. The Rochelle salt (K-Na-tartarate) 
contained in the Biuret reagent is utilized to keep the formed cupric 
hydroxide in solution which gives the blue colour. The intensity of the 
colour produced is proportional to the amount of protein in the sample.  
The absorbencies of the sample (A sample) and of the standard (A 
standard) were read against the reagent blank in the Spectrophotometer at 
a wavelength of 545nm. The total serum protein concentration (C) was 
calculated as follows:   
 
C(g/dl) = A sample × concentration of standard A standard 
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2. 2. 3. 2 Albumin 
          Serum albumin was measured by a colourimetric method using a 
commercial kit (Roandox Laboratories Ltd., U.K.). 
Test principle 
          The measurement of serum albumin is based on its quantitative 
binding to the indicator 5, 5-dibromo- o-cresolsulphonphthalin 
(bromocresol purple, BCP). 
          Serum was mixed with a buffered BCP reagent and the mixture was 
incubated for 2 minutes at room temperature. The absorbance of the 
sample (A sample) and of the standard (A standard) was measured against 
the reagent blank at a wavelength of 600nm and albumin concentration 
(C) was calculated as follows:   
                  
C(g/dl) = A sample × concentration of standard A standard 
  
2. 2. 3. 3 Sodium 
          Serum Sodium concentration was determined by flame photometry 
as described by Varley (1967). The method is based on passing, under 
controlled conditions, a diluted serum (1:100) as a very fine spray in the 
air supply to a burner where the solution evaporates and the salt 
dissociates to give neutral atoms. Light of characteristic wavelength was 
emitted and passed through a specific filter for sodium on to a photocell 
and the amount of current produced was read on galvanometer. The air 
pressure was adjusted to 10 lb per square inch and butane gas was used 
for the flame. 
          The spray was formed by passing compressed air through an 
atomizer into which the diluted serum was drawn by suction and then 
entered the burner with its air supply. The gas and air pressures were 
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carefully regulated in order to maintain a constant and steady flame. 
Changes in the galvanometer readings were recorded and values were 
estimated in mEq/Litre as follows: 
  
                                 140)/(  ×=
S
TLmEqionconcentratSodium  
 
The values were then converted to mg/100ml. 
T = tested; S = standard and 140 = factor.                                         
2. 2. 3. 4 Potassium 
          The method described by Varley (1967) for the determination of 
serum potassium is based on the same principle of flame photometry as in 
case of serum sodium. The sensitivity of the instrument was varied in 
order to use the same dilution of serum (1:100) for both sodium and 
potassium. Light of characteristic wavelengths was emitted and passed 
through a specific filter for potassium on to a selenium cell and the 
amount of current produced was measured. Changes in the galvanometer 
readings were recorded and values were estimated in mEq/liter as 
follows:  
Potassium concentration(mEq/L) = T × 5 S 
                            
The values were then converted to mg/100ml.  
T = tested; S = standard and 5 = factor.                                         
2. 2. 3. 5 Calcium 
          Serum calcium concentration was determined by a colourimetric 
method using a commercial kit (Randox Laboratories Ltd., U.K.). 
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Test principle 
          Calcium ions form a violet complex with chromogen (O- 
Cretholphthalein complexone -8- hydroxyquinoline hydrochloric acid) in 
an alkaline medium (2- amino- 2- methyl- propan- 1- 01). 
 Serum was mixed with a buffered reagent and the absorbance of the 
sample (A sample) and of the standard (A standard) was measured against 
reagent blank at wavelength of 578nm and calcium concentration (C) was 
calculated as follows: 
C(g/dl) = A sample × concentration of standard A standard 
 
2. 2. 3. 6 Glutamate oxaloacetate transaminase (Aspartate 
aminotransferase, L-Aspartate; 2- oxoglutarate aminotransferase, E. 
C. 6. 1. 1; GOT, AST) 
          Serum AST activity was measured by a commercial kit (Randox 
Laboratories Ltd, U.K.). 
Test principle 
          Aspartate aminotransferase catalyses the reversible transfer of an 
amino group from aspartate to α-ketoglutarate forming glutamate and 
oxalacetate: 
          L-aspartate + α-ketoglutarate ?GOT? L-glutamate + oxalacetate 
          The oxalacetate produced is reduced to malate by dehydrogenase 
MDH and NADH. 
         Oxalacetate + NADH + H+ ? NADH ? L-Malate + NAD 
           
The rate of decrease in concentration of NADH is proportional to the 
catalytic concentration of AST present in the serum sample. 
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Protocol:  
          Non-haemolysed serum was added to a buffered substrate mixture 
of L-aspartate and α-oxoglutarate. The absorbance at a wavelength of 
365nm was read at one minute intervals after mixing the serum with the 
buffered substrate solution. The mean absorbance change per minute 
(A365/minute) was used for calculation of enzyme activity as follows: 
          IU = A365 nm/minute  2059 
2. 2. 3. 7 Alanine amino transferase, ALT (Glutamic pyruvic 
transaminase, L- aspartate, 2- oxoglutamate, GPT) 
          It is enzymatic method, which measures glutamic pyruvic 
transaminase in sera by monitoring the concentration of pyruvic 
hydrazone formed with 2-4 dinitrophenyl hydrazine.  
Test principle:  
          Oxoglutarate + L-alanine ?GPT?  L-glutarate + Pyruvate 
          The absorbance of samples was read against the reagent blank after 
5 minutes at wavelength of the 630nm UV/VIS Spectrophotometer. The 
GPT was measured in U/L. 
2. 2. 4 Statistical methods 
          Data derived from blood, sera and faeces’ weight were expressed as 
means ± S.E. Statistical differences between mean values were analyzed 
by a completely randomized design; using one way ANOVA (Analyses 
of Variance) followed by Duncan’s Multiple Range Test with aid of SAS 
computer programme (SAS, 1998). P<0.05 was considered significant. 
The efficacies were obtained by calculating the differences between the 
faeces weight in the treated and the control group and the values were 
transformed into percentage using mean index in the formula: 
                              (a-b)/a*100 = efficacy 
Were a is mean of the faeces weight in the control and b the faeces 
weight in the treated rats (Snedecor and Cochran, 1989). 
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CHAPTER THREE 
RESULTS 
 
3. 1 Effect of Hydnora abyssinica roots aqueous extract on castor oil 
induced diarrhoea in rats  
 3. 1. 1 Clinical signs 
          Rats in groups, 2 (100mg/kg), 3 (200mg/kg) and 4 (400mg/kg) 
showed no clinical sings during the experimental period (24 hours) and 
no mortalities were recorded. Group 5, which is treated, showed also 
normal behavior and no mortalities. In the un-treated control rats (group 
1) there were copious diarrhoea seen but also no mortalities were 
recorded.   
3. 1. 2 Pathological changes 
          For all test groups 2, 3, 4 and 5 no gross changes were observed at 
postmortem at the end of the experiment (24 hours). Normal organs were 
also observed in the control group (group 1). 
3. 1. 3 Effect of Hydnora abyssinica roots aqueous extract on faecal 
weight of diarrhoeic rats 
          The effects of the aqueous extract of Hydnora abyssinica roots on 
castor oil induced diarrhoea in rats are shown in Table (1). The effect of 
the plant extract on weight of faeces and the inhibition percentage the 
extract produced are shown in figure (4) and figure (5) respectively.  
          The aqueous extract of Hydnora abyssinica exhibited marked dose 
dependent anti-diarrhoeal activity in the study. The extract significantly 
inhibited both the frequency of defecation as well as the weight of faecal 
matter in rats.  
         Rats of group 2(100mg/kg) demonstrated a significant (P<0.05) 
decrease in faeces weight in the fourth and sixth hours, as compared with 
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the control group (castor oil group), showing efficacy rates of 46.78 and 
27.42% respectively.    
          Group 3(200mg/kg) rats indicated significant (P<0.05) difference 
in weight of faeces when compared with the control group (un-treated 
group) in the fourth and sixth hours with inhibition percentage of 63.21 
and 50.88% respectively. 
          Rats of group 4(400mg/kg) showed highly significant (P<0.05–
0.001) decrease in weight of faeces when compared with the control 
group (un-treated group) at the fourth and sixth hours and providing 
highly inhibition rates of 74.68 and 60.13% respectively. 
          Group 5 (Loperamide) rats also showed highly significant 
(P<0.05–0.001) difference in the weight of faeces when compared with 
the control group (un-treated group) in the fourth and sixth hours and 
recorded higher inhibition percentage of 66.54 and 72.21% respectively. 
          Generally, the highest inhibition percentage obtained in this study 
was 74.68% with the dose 400mg/kg body weight of the extract which 
was comparatively greater than 72.21%, the maximum inhibition 
percentage produced by loperamide. 
3. 1. 4 Changes in serum metabolites  
          Table 2 and Table 3 show the changes in serum metabolites of rats 
treated orally with Hydnora abyssinica roots aqueous extract at 4 and 24 
hours respectively. 
          At 4 hours, the values of total protein and sodium showed 
significant (P<0.05) increase in groups 3, 4 and 5 when compared with 
the control group. Also, the values of albumin in groups 4 and 5 
demonstrated significant (P<0.05) increase. The concentration of calcium 
only in groups 4 and 5 showed significant (P<0.05) decrease while 
potassium in all groups demonstrated significant increase when compared 
with the control group.   
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Table 1. Effect of Hydnora abyssinica roots aqueous extract on 
castor oil–induced diarrhoea in rats 
 
Hours Groups 
Dose 
mg/kg 
Faeces weight 
mg 
Inhibition
% 
 
 
 
 
 
4hrs 
 
G1 un-treated control 
(saline)+ castor oil 
01.89± 00.01 a 00.00 
G2  100mg/kg H.aby. 
+ castor oil 
01.01 ± 00.00 b 46.78 
G3  200mg/kg H.aby. 
+ castor oil 
00.70 ± 00.03 c 63.21 
G4 400mg/kg H.aby.  
+ castor oil 
00.48 ± 00.01 e 74.68 
G5 3mg/kgLopramide
+castor oil 
00.63 ± 00.01 d 66.54 
 
 
 
 
 
6hrs 
G1 un-treated control  
(saline)+ castor oil 
02.15 ± 00.00 a 00.00 
G2 100mg/kg H.aby.  
+ castor oil 
01.56 ± 00.01 b 27.42 
G3  200mg/kg H.aby. 
+  castor oil 
01.06 ± 00.02 c 50.88 
G4  400mg/kg H.aby. 
+ castor oil 
00.87 ± 00.03 d 60.13 
G5 3mg/kgLopramide
+castor oil 
00.60 ± 00.00 e 72.21 
Values are mean ± S.E.M; Means in a column bearing same subscript are similar 
(not significantly different P > 0.05). 
H.aby. = Hydnora abyssinica 
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Fig. (4): Comparison of faeces weight in diarrhoeic rats treated with 
Hydnora abyssinica aqueous extract 
 
G1  (un-treated control) saline  + castor oil 
G2  100mg/kg H.abyssinica      + castor oil 
G3  200mg/kg H.abyssinica      + castor oil 
G4  400mg/kg H.abyssinica      + castor oil 
G5  3mg/kg Lopramide             + castor oil 
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G1  (un-treated control) saline  + castor oil 
G2  100mg/kg H.abyssinica      + castor oil 
G3  200mg/kg H.abyssinica      + castor oil 
G4  400mg/kg H.abyssinica      + castor oil 
G5  3mg/kg Lopramide             + castor oil 
 
 
Fig. (5): Comparison of inhibition percentage of faeces weight in 
diarrhoeic rats dosed orally with Hydnora abyssinica 
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At 24 hrs the concentration of total protein and calcium showed increases 
in all groups while sodium, potassium and albumin demonstrated no 
significant changes in concentrations.  
3. 1. 5 Haematological findings 
          Table 4 is summarizing the haematological changes in rats blood 
treated orally with Hydnora abyssinica aqueous extract for 24 hours. 
          In all groups, there is significant increase (P<0.05) in values of 
RBCs and Hb concentration when compared with the control group. All 
groups showed significant decrease (P<0.05) in PCV and MCHC while 
values of MCV demonstrated no changes when compared with the 
control group. 
 
3. 2 Response of Albino rats to Hydnora abyssinica aqueous extract 
3. 2. 1 Clinical changes  
          Rats in groups 2 (400mg/kg), 3 (800mg/kg) and 4 (1600mg/kg) 
showed no signs of toxicity during the experimental period (7 days) and 
no mortalities were recorded. Also, no abnormal behavior was observed 
in the un-dosed control rats (group 1) and no deaths too. 
3. 2. 4 Changes in serum metabolites 
          Table 5 and Table 6 demonstrate the changes in serum metabolites 
of rats treated with Hydnora abyssinica aqueous extract for 7 days. 
          The activities of AST and ALT showed no significant changes 
(P>0.05) for all groups at day zero. Also concentrations of sodium, 
potassium, total protein and albumin of the test groups demonstrated no 
significant (P>0.05) changes from the control group. No abnormal values 
were recorded in the control group at day zero.  
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Table 2. Values of serum metabolites of orally treated rats with Hydnora abyssinica 
roots aqueous extract at 4 hours 
 
 
Groups/dose 
Total Protein 
g/dl 
Albumin  
g/dl 
Sodium  
mg/dl 
Potassium 
mg/dl 
Calcium  
mg/dl 
G1 un-treated control 
(saline) + castor oil 
02.24 ± 00.17c 01.76 ± 00.21 b 106.30 ± 01.93c 00.98 ± 00.07 c 14.18 ± 00.20 b 
 G2 100mg/kg H.abyssinica    
+ castor oil 
02.70 ± 00.12c 02.00 ±00.18ab 106.50 ± 01.42c 01.24 ±00.09ab 14.10 ± 00.15bc 
 G3 200mg/kg H.abyssinica  
+ castor oil 
03.22 ± 00.15b 02.26 ±00.07ab 117.78 ±01.42b  01.44 ±00.15ab 14.06 ±00.16 bc 
G4 400mg/kg H.abyssinica   
+ castor oil 
04.52 ± 00.16a 02.50 ± 00.17 a 139.26 ±00.67a 01.74 ± 00.12 a 13.64 ± 00.10 c 
G5 3mg/kg loperamide 
+castor  oil 
04.32 ± 00.19a 02.50 ± 00.15 a 137.30 ±00.46a 01.78 ± 00.11 a 12.76 ± 00.21 d 
         Values are average (mean ± S.E.M.). 
        Means in a column bearing same subscript are similar (not significantly different P > 0.05). 
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Table 3. Values of serum metabolites of treated rats with Hydnora abyssinica 
aqueous extract at 24 hours. 
 
 
Groups/dose 
Total protein  
g/dl 
Albumin 
 g/dl 
Sodium 
 mg/dl 
Potassium 
mg/dl 
Calcium  
mg/dl 
G1 un-treated control 
(saline) + castor oil 
04.96 ± 00.27 b 03.46 ± 00.22 a 134.80 ± 02.07 ab 05.28 ± 00.19 b 11.56 ± 00.13 c 
 G2 100mg/kg H.abyssinica   
+ castor oil 
06.00 ± 00.19 a 03.10 ± 00.10 ab 135.50 ± 01.65 a 05.68 ± 00.21 ab 12.46 ± 00.18 b 
 G3 200mg/kg H.abyssinica   
+ castor oil 
06.16 ± 00.25 a 03.18 ± 00.14 ab 131.76 ± 00.99 b 05.80 ± 00.30 ab 12.40 ± 00.16 b 
G4 400mg/kg H.abyssinica   
+ castor oil 
05.98 ± 00.16 a 03.00 ± 00.15 ab 135.00 ± 00.91 ab 06.00 ± 00.22 ab 13.60 ± 00.19 a 
G5 3mg/kg loperamide  
+ castor  oil 
06.58 ± 00.17 a 03.30 ± 00.14 a 132.26 ± 00.81 ab 05.70 ± 00.20 ab 12.68 ± 00.14 b 
         Values are average (mean ± S.E.M.). 
        Means in a column bearing same subscript are similar (not significantly different P > 0.05). 
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Table 4. Haematological values of rats treated with Hydnora abyssinica 
aqueous extract at 24 hours. 
 
 
Groups/dose RBCS.106/mm3 Hb (g/dl) PCV% MCV(fl) MCHC% 
G1 un-treated control 
(saline) + castor oil 
05.21 ± 00.17 b 10.48 ± 00.19b 39.54 ± 00.28 a 64.06 ± 00.26 ab 35.54 ± 00.22 a 
 G2 100mg/kg H.abyssinica       
+ castor oil 
05.49 ± 00.10 a 11.52 ± 00.15 a 37.16 ± 00.61 b 62.96 ± 01.35 b 33.88 ± 00.26 b 
 G3 200mg/kg H.abyssinica  
+ castor oil 
05.52 ± 00.19 a 11.58 ± 00.29 a 33.76 ± 00.50 c 63.24 ± 00.39 b 34.30 ± 00.34 b 
G4 400mg/kg H.abyssinica   
+ castor oil 
05.43 ± 00.18 a 12.08 ± 00.18 a 32.08 ± 00.16 d 65.38 ± 00.47 a 33.50 ± 00.33 b 
G5 3mg/kg loperamide 
+castor  oil 
05.56 ± 00.16 a 11.92 ± 00.97 a 33.70 ± 00.31 c 63.82 ± 00.94 b 33.64 ± 00.19 b 
  Values are average (mean ± S.E.M.). 
  Means in a column bearing same subscript are similar (not significantly different P > 0.05). 
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At day 8, the values of serum ALT, total protein and albumin of the tested 
groups showed no significant changes (P<0.05) when compared with the 
control group while the concentrations of AST, sodium and potassium 
showed significant (P<0.05) increase in groups 3 and 4. Normal values 
were recorded for the control group. 
  
3. 2. 5 Haematological findings 
 
 Table 7 and Table 8 indicate the haematological changes in blood 
of rats dosed orally with Hydnora abyssinica roots aqueous extract for 7 
days. 
 
          The RBCs, Hb, PCV, MCV and MCHC concentrations represent no 
significant changes for all groups at day zero. No abnormal values were 
recorded from the control group.  
          At day 8, treatment effect showed significant (P<0.05) decrease in 
the number of RBCs, concentrations of Hb and PCV values. MCV for all 
groups showed no significant (P>0.05) change when compared with the 
control group while MCHC demonstrated significant increase. Normal 
values were recorded for the control group. 
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Table 5. Values of serum metabolites of rats dosed orally with Hydnora abyssinica 
aqueous extract at day zero 
 
 
 
Groups/dose 
 
Sodium 
Mg/dl 
Potassium 
mg/dl 
Total Protein 
g/dl 
Albumin 
g/dl 
ALT 
(i.u/l) 
AST 
(i.u/l) 
G1un-dosed 
control 
146.40±01.24a 05.08±00.29 a 07.37±00.13 a 04.30±00.13 a 36.60±00.40 a 126.60±01.29a 
G2 400mg/kg 
H.abyssinica  
146.47±01.11a 05.02±00.16 a 07.23±00.19 a 04.26±00.11 a 36.00±00.63 a 128.40±02.50a 
G3 800mg/kg 
H.abyssinica   
146.53±01.08a 04.92±00.11 a 07.31±00.13 a 04.32±00.10 a 37.00±01.63 a 129.00±02.43a 
G4 1600mg/kg 
H.abyssinica 
146.60±00.87a 05.06±00.17 a 07.40±00.11 a 04.30±00.17 a 37.60±00.40 a 127.60±01.78a 
   Values are average (mean ± S.E.M.). 
   Means in a column bearing same subscript are similar (not significantly different P > 0.05). 
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Table 6. Values of serum metabolites of rats dosed orally with Hydnora abyssinica 
aqueous extract at day 8 
 
 
 
 
Groups/dose 
 
Sodium  
Mg/dl 
Potassium  
mg/dl  
Total protein  
g/dl 
Albumin 
 g/dl 
ALT 
(i.u/l) 
AST 
(i.u/l) 
G1un-dosed 
control 
142.40±00.68 c 04.80±00.14 c 07.56±00.02 a 04.20±00.09 a 39.60±00.40 b 135.00±02.30 c 
G2 400mg/kg 
H.abyssinica  
143.20±00.66c 04.96±00.13bc 07.50±00.20 a 04.20±00.09 a 39.00±00.45 b 136.40±03.30 c 
G3 800mg/kg 
H.abyssinica   
144.80±00.58b 05.30±00.11ab 07.37±00.12ab 04.18±00.09 a 40.00±01.41 b 138.00±03.15b 
G4 1600mg/kg 
H.abyssinica 
147.00±00.71a 05.40±00.07 a 07.46±00.08ab 04.34±00.15 a 40.60±00.40 b 140.30±07.41a 
  Values are average (mean ± S.E.M.). 
  Means in a column bearing same subscript are similar (not significantly different P > 0.05). 
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Table 7. Haematological values of rats dosed orally with Hydnora abyssinica 
aqueous extract at day zero 
 
 
 
 
Groups/dose 
 
RBCS.106/mm3 Hb (g/dl) PCV % MCV (fl) MCHC % 
G1un-dosed 
control 
09.49±00.15 a 14.48±00.05 a 35.86±00.12 a 52.67±01.00 a 33.02±00.43 a 
G2 400mg/kg 
H.abyssinica  
09.97±00.10 a 14.40±00.16 a 35.96±00.17 a 52.71±01.02 a 33.22±00.49 a 
G3 800mg/kg 
H.abyssinica   
09.50±00.17 a 14.54±00.13 a 35.94±00.26 a 52.60±00.87 a 33.00±00.45 a 
G41600mg/kg 
H.abyssinica 
09.26±00.10 a 14.50±00.14 a 35.88±00.18 a 52.80±01.24 a 33.17±00.19 a 
   Values are average (mean ± S.E.M.). 
   Means in a column bearing same subscript are similar (not significantly different P > 0.05). 
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Table 8. Haematological values of rats dosed orally with Hydnora abyssinica 
aqueous extract at day 8 
 
 
 
 
Groups/dose 
 
RBCs.106/mm3 Hb(g/dl) PCV% MCV(fl) MCHC% 
G1un-dosed 
control 
09.31±00.13 a 14.46±00.16 a 35.80±00.21 a 54.00±01.38 a 31.60±00.27 b 
G2 400mg/kg 
H.abyssinica  
08.58±00.19 b 13.80±00.10 b 35.60±00.22 b 54.80±00.58 a 33.02±00.29 a 
G3 800mg/kg 
H.abyssinica   
08.53±00.08 b 13.72±00.18 b 35.00±00.09 b 55.80±00.45 a 32.86±00.22 a 
G41600mg/kg 
H.abyssinica 
08.55±00.12 b 13.90±00.09 b 34.90±00.23 b 53.20±01.53 a 33.30±00.21 a 
  Values are average (mean ± S.E.M.). 
  Means in a column bearing same subscript are similar (not significantly different P > 0.05). 
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CHAPTER FOUR 
DISCUSSION 
          Diarrhoea is not a disease, but a symptom of some other problems. 
However, diarrhoea is the most common and economically devasting 
health problem of farm animals that cause significant losses in both herd 
and production despite improvements in management practices, 
prevention and treatment strategies. A study at the U. S. Sheep 
Experiment Station (Dubois, ID) showed that diarrhoea accounted for 
46% of lamb mortality (Schenian, 2009).  
          In man also acute diarrhoea constitutes a serious problem 
worldwide. It is a leading cause of morbidity and mortality among 
children in the developing countries (Coker et al., 1998). However, 
according to the WHO, (2004) mortality from diarrhoea has declined over 
the past two decades from an estimated 5 million deaths among children 
under five to 1.5 million deaths in 2004. Despite these declines, diarrhoea 
remains the second most common cause of death among children under 
five globally, following closely behind pneumonia, the leading killer of 
young children. Together, pneumonia and diarrhoea account for an 
estimated 40% of all child deaths around the world each year. Nearly one 
in five child deaths is due to diarrhoea, a loss of about 1.5 million lives 
each year. The toll is greater than that caused by AIDS, malaria and 
measles combined. Therefore, the search for new anti-diarrhoeal drugs 
should still be seen as a fruitful and logical research strategy, hence it is 
important and useful to identify plants with anti-diarrhoeal activity 
(Agbor et al., 2003) because medicinal plants are important for 
pharmacological research and drug development, not only when plant 
constituents are used directly as therapeutic agents, but also as starting 
materials for the synthesis of drugs or as models for pharmacologically 
active compounds.  
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          Numerous studies have validated the traditional use of anti-
diarrhoeal medicinal plants by investigating the biological activity of their 
extracts which can act by many different ways; delaying the intestinal 
transit time, suppressing gut motility, stimulating water adsorption, 
reducing electrolytes secretion or having anti-spasmodic effects. Tannins 
and flavonoids, for instance, are some of the phytochemicals present in 
these extracts and thought to be responsible for anti-diarrhoeal activity by 
increasing colonic water and electrolyte reabsorption, and so on. 
          In this study, evaluation of anti-diarrhoeal activity and investigation 
of toxicity of aqueous root extract of Hydnora abyssinica were carried 
out. The inhibition of experimental diarrhoea and the reduction in faecal 
output by a substance are the basis of the pharmacological evaluation of a 
potential anti diarrhoeal agent. 
          Castor oil causes diarrhoea due to its active metabolite ricinoleic 
acid which induces permeability changes in mucosal fluid and electrolyte 
transport that result in hyper secretory response and diarrhoea (Ammon et 
al., 1975 and Gaginella et al., 1975). Ricinoleic acids produces irritation 
and inflammation of the intestinal mucosa leading to release of 
prostaglandin-E2 (PG-E2) which markedly increases in portal venous and 
gut lumen resulting in stimulation of motility and secretion of water and 
electrolytes into the small intestine (Pierce et al., 1971, Beubler et al., 
1979, Luderer et al., 1980). As the précised mechanism of action of 
castor oil is through elevated prostaglandin biosynthesis hence, inhibition 
of prostaglandin biosynthesis delayed castor oil induced diarrhoea 
(Awouters et al., 1978, Bruton, 1985). 
Loperamide, which is at present one of the most efficacious and widely 
employed anti-diarrhoeal drug, was used in this study as a standard anti-
diarrhoeal compound. Loperamide effectively antagonized the diarrhoea 
induced by castor oil (Neimegeer et al.1974), prostaglandin (Karim and 
 63
Adikan, 1977) or cholera toxin (Farack et al., 1981). The therapeutic 
effect of the Loperamide is believed to be due to its antimotility and 
antisecretary activity (Couper, 1987). 
The results of this study revealed that the aqueous extract of 
Hydnora abyssinica roots against castor oil induced diarrhoea in rats 
showed highly inhibition percentage in weight of faeces at all doses used 
(100, 200 and 400mg/kg body wt. /rat) and this inhibition was 
accompanied by a dose dependent decrease. An interesting observation 
finding in this extract is that the minimum dose (100mg/kg) of the extract 
was able to inhibit castor oil-induced diarrhoea from the earliest hours 
and this may be due to sufficient absorption of the extract beside that the 
extract may contain potent anti-diarrhoeal ingredients. Moreover, the 
maximum dose of the extract (400mg/kg) showed almost similar anti-
diarrhoeal activity as that of Loperamide (3mg/kg) after 6 hours and even 
better than the reference compound Loperamide at 4 hours. The inhibitory 
effect of the plant extract justified the use of the plant as a non-specific 
anti-diarrhoeal agent in folkloric medicine.   
Furthermore, our findings are in agreement with the anti-diarrhoeal 
activities reported in other medicinal plants against diarrhoea in rats. In a 
similar study, Sini et al. (2008) evaluated the anti-diarrhoeal activity of 
the aqueous extract of Combretu sericeium roots, which was previously 
reported by Abdulahi et al. (2003) as traditional treatment of diarrhoea in 
West Africa, against castor oil induced diarrhoea in rats and found that 
the extract (25 and 50mg/kg body wt.) causes a dose dependent protection 
against castor oil induced diarrhoea. A phytochemical screening of the 
extract revealed the presence of tannins, flavonoids, glycosides, 
anthraquinones and alkaloids. Viswanatha et al., (2007) reported 
inhibition of weight of the induced diarrhoea by plants known as 
Thespesia populenea.   
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         Also, the pretreatment of mice with Stereospermum kuthianum 
aqueous extract (100, 200 and 400mg/kg body wt.) caused a dose-
dependent and significant (P<0.05) delay in the onset of diarrhoea, 
frequency of stooling, decreased weight of wet stools and the general 
diarrhoeal score in mice and this is a possible reason for its anti-
diarrhoeal use in traditional medicine. The extract also produced no 
mortalities in mice at a maximum oral dose of 8g/kg; it is there well 
tolerated and relatively safe by oral route (Ching et al., 2008). 
In this study, also the daily doses of aqueous extract of Hydnora 
abyssinica roots administrated orally to rats caused neither death nor any 
observable clinical toxicity signs in rats during the experimental period 
(seven days) at the doses used. Even a dose as high as 1600mg/kg body 
wt/rat/day, showed neither death nor any untoward clinical signs. Hence 
the extract was found to be safe and well tolerated till 1600mg/kg body 
wt. 
The dose (1600mg/kg) equals sixteen times the least extract dose 
(100mg/kg) that showed significant inhibition in weight of the induced-
diarrhoea and this supports the suggestion that the extract has a wide 
range of safety and its administration may not cause immediate toxic 
effect at least at the doses used in this study. 
Viswanatha et al., (2007) studied the acute toxicity of the aqueous 
and alcoholic extracts of stem barks of Thespesia populenea (Malvaceae). 
Studies revealed that both the extracts are safe up to 2000mg/kg. The 
extracts also showed significant dose dependent reduction of cumulative 
wet mass when investigated for their anti-diarrhoeal activity on castor oil 
induced diarrhoea model in rodents. However, it was observed that 
aqueous extract is having more potent anti-diarrhoeal activity than 
alcoholic one.  
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The activities of enzymes AST and ALT in the serum were used 
routinely to assess the functional status of the liver in both clinical and 
experimental settings (Yanpellewar et al., 2002). In our study we 
observed that there was no change in the concentrations of ALT, while in 
the AST values there were increase in the doses 800mg/kg and 
1600mg/kg and this may be due to highly doses but not indicated toxicity 
because not only the increase in serum levels of these hepatic markers but 
also in billuribin beside the correlated histopathlogical changes in the 
liver can assess hepatic damage.  
On the other hand, the increase in the total protein and albumin was 
a positive indicator that routinely used for the assessment of the renal 
toxicity (Ahmed and Adam, 1979 and Medani, 2003). The present study 
showed that there was no increase in the concentration of total protein 
and albumin when compared to the un-dosed control group at the end of 
the experiment and that indicates the safety of the plant. On the other 
hand, sodium and potassium showed at doses 800 and 1600mg/kg body 
wt. increase in concentrations.      
In this study, haematological values of rats dosed orally with 
Hydnora abyssinica decrease in the number of RBCS, concentration of 
Hb and PCV.  MCV showed no significant while values of MCHC 
increased in all groups. 
The results obtained in this study showed that the extract 
significantly reduced the weight of faeces of the induced diarrhoea in rats 
indicate the anti-diarrhoeal activity of the plant suggesting that the active 
principles are present in the extract may act as anti-diarrhoeal. It is well 
established that the release of several mediators such as prostaglandins, 
some plants’ constituents can significantly inhibit the biosynthetic 
pathway of these mediators (Speroni et al., 2005). Based on these 
observations, it seems that the anti-diarrhoeal effect of Hydnora 
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abyssinica aqueous extract may be due to the inhibition of prostaglandin 
biosynthesis or by decreasing the peristaltic movement. However, the 
mechanism of inhibition is unknown since the exact active ingredients 
responsible for inhibition were not determined. On further 
characterization and purification of the active ingredients, more potent 
compounds can be produced.  
Conclusion 
?  The aqueous extract of Hydnora abyssinica possesses anti-
diarrhoeal activity verified by the highly percentage of 
inhibition effected by the extract in weight of faeces. We 
concluded that, the extract is promising an effective anti-
diarrhoeal agent and this provide evidence that supports the 
claim of traditional use of the plant in treating diarrhoea. 
? Hydnora abssinica aqueous extract showed no signs of 
toxicity to rats up to 1600mg/kg revealed that the extract is 
well tolerated and relatively safe by oral route.  
Recommendations 
? Further detailed investigations on the phytochemical 
constituents present in this extract are needed to test their anti-
diarrhoeal potential and to clarify the mode of action of the 
extract.  
? Testing of other methods of plants’ extraction is needed to 
reveal if one extract is having more potent anti-diarrhoeal effect 
than others. 
? The study has also, demonstrated details of the oral toxicity of 
H. abyssnica aqueous extract to rats for a period of seven days. 
Studies are needed to investigate this extract for a longer period 
using higher doses. 
 
 67
 
 REFERENCES 
 
 
AbdelGadir, B. S. (2004). Isolation and characterization of ETEC 
causing diarrhoea in calves and man. M. V. M thesis University of 
Khartoum Sudan. 
Abdullahi, A. L., Agho, M. O., Amos, S., Gamaniel, K. S. and 
Wambebe, C., (2001). Anti-diarrhoeal activity of aqueous extract of 
Terminalia avicennoides roots. Phytoter. Res. 15: 431- 434, Nigeria. 
Abdullahi, M., Muhammad, G., Abdulkadir, N. U. (2003). 
Combretaceae. Medicinal and Economic Plants of  Nupeland, p.68. 
Acres, S. D. Laing, C.J; Sudaners, J. R. (1975). Acute undifferentiated 
neonatal diarrhoea in beef calves. Occurrence and distribution of 
infectious agents. Canadian Journal of comparative medicine, 39: 116-
132. 
Adam, S. E. I. (1978). Toxicity of indigenous plants and agricultural 
chemicals in farm animals. Clinical Toxicology, 13, 269.  
Agbor, G. A.; Léopold, T. and Jeanne, N. Y., (2003). Medicinal Plants 
and Traditional Medicine Research Centre, Institute of Medical Research 
and Medicinal Plants Studies, University of Yaounde I, Cameroon. 
Ahmed, O. M. M. and Adam, S. E. I. ( 1979). Toxicity of Jatropha 
curcas in sheep and goats. Research in Veterinary Science, 27, 89-96. 
Aiello, S. E. and Mays, A. (1998). The Merck Veterinary Manual. 8th ed. 
Merck and Co. Inc., Whitehouse Station, N J, USA and Merial Limited.  
 68
Akah, P. A. P. A., Aguwa, C. N., Agu, R. U., (1998). Studies on the 
anti-diarrhoeal properties of Pentaclethra macrophylla leaf extracts 
Department of Pharmacology and Toxicology, University of Nigeria, 
Nigeria.   
Ali, K. H. (2000). Studies on collibacillosis infectious diarrhoea in 
calves, sheep and goat. M. V. Sc. Thesis, University of Khartoum. 
Ammon, H. V., Thomas, P. J. Bass, P. (1975). Effect of oleic acid and 
ricinoleic on net jejunum water and electrolyte movement. J. Clin. Invest. 
53: 374- 379. 
Amstutz, H. E. (1965). Occurance and etiology of infectious calf 
diarrhoea. JAVMA, 147: 1360- 1363. 
Anderson, B. C. and Hall, R. F. (1985). Cryptosporidial infection in 
Idaho diary calves. JAVMA, 181: 484– 485. 
Atta, A. H. and Mouneir, S. M. (2004a). Antidiarrhoeal activity of some 
Egyptian medicinal plant extracts. Department of Pharmacology, Faculty 
of Veterinary Medicine, Cairo University, Giza 12211, Egypt. 
Atta, A. H. and Mouneir, S. M. (2004b). Evaluation of some medicinal 
plant extracts for anti-diarrhoeal activity Department of Pharmacology, 
Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt. 
Awouters, F., Nimegrees, C. J. E., Lanaerts, F. M., Janssen, P. A. J. 
(1978). Delay of castor oil in rats: A new way to evaluate inhibitors of 
prostaglandin biosynthesis. J. Pharmacol. 30: 41-5. 
Babuik, L. A., Sabara, M. And Hudson, G. R. (1985). Rotavirus and 
coronavirus infections in animals. Progress Vet. Microbiol. Immun. Vol. 
1. (Pandey, R. ed.). Karger, Basel, Switzerland. pp. 80–120. 
 69
Bachmann, P. A. (1982). Comparative aspects of pathogenesis and 
immunity in animals. Virus infection of gastrointestinal tract (D. A. J. 
Tyrell, A. Z. Kapikian; eds.). Marcel Dekker, Inc., New York, pp. 361-
397. 
Baljer, G. (1986). Therapy and prophylaxis of diarrhoea in new born 
calves. Proveterinario, 2: 6-8.  
Beentje, H., and Luke, Q. (2002). Flora of Tropical East Africa, page 1. 
Behrman, R. E., Kliegman, R. M. and Jenson, S. B. (2004). Nelson’s 
Text Book of Pediatrics. 17th ed. Sadaners, Anim. Print of Elsevoier 
Science. New York. London. 
Benfield, D. A. and Saif, L. J. (1990). Cell culture propagation of corona 
virus isolated from cows with winter dysentery. Clin. Microbiol., 28 
(6):1454-1457. 
Besra, S. E., Gomes, A., Chaudhury, L., Vedasiromoni, J. R. and 
Ganguly, D. K. (2000). Anti-diarrhoeal activity of seed extract of 
Albizzia lebbeck Benth. Division of Pharmacology and Experimental 
Therapeutics, Indian Institute of Chemical Biology. 
Beubler, E., Juan, H. (1979). Effect of ricinoleic acid and other laxatives 
on net water flux and prostaglandin E release by the rat colon. J. 
Pharmacol. 31: 681-685. 
Blood, D. C., Radositis, O. M., Henderson, J. A., Arundel, J. H. and 
Gray, C. C. (1983). Veterinary Medicine, 6th ed., Bailliere Tindall 
Pitman Press Ltd. London, England, pp. 557–570/ 767–774. 
Boulos, I. (1983). Medicinal plants of North Africa. Reference 
Publications, Inc. (pub). USA. 
 70
Bruton, L. L. (1985). Agents affecting gastrointestinal water flux and 
motility digestant; and bile acids. In; A. G. Gillman, T.W. Rail, A.S. Nies 
and P. Taylor, Editors, Pharmacol. Basis of Therapeutics, 8th ed, vol. 2, 
Mc Graw, NewYork, p. 14. 
Castrucci, G., Figeri, F., Angellio, V., Ferrari, M., Cilli, V. and 
Alidrovandi, V. (1987). Field trail evaluation of an inactivated rotavirus 
vaccine against neonatal diarrhoea of calves. Eur. J. Epidemiol., 3 (1): 5- 
9. 
Chaves, M. C., Santos, F. A., Menezes, A. M. S. and Rao, V. S. N., 
(1998). Experimental evaluation of Myracrodruon urundeuva barks 
extract for anti-diarrhoeal activity. Departmento de Fisiologia e 
Farmacologia, Universidade Federal do Ceará, Centro de Ciências da 
Saúde, C.P. 3157, 60430-270 Fortaleza, CE, Brazil Per Claeson, Gunnar 
Samuelsson.  
Ching, F. P., Omogbai, E. K. I., Ozolua, R. I. and Okpo, S. O. (2008). 
Antidiarrhoeal activities of aqueous extract of Stereospermum 
kunthianum stem bark in rodents. Nigeria. African Journal of 
Biotechnology Vol. 7 (9), PP. 1220- 1225. 
Ciba Found Symp. (1994). Ethnopharmacological investigation of 
Chinese medicinal plants. 185: 169- 73; discussion 173-7. Institute of 
Medicinal Plant Development, Chinese Academy of Medical Sciences, 
Beijing. 
Clarke; Myral; Harvey, D. G. and Humphreys, D. J. (1981). 
Veterinary Toxicology 2ed ed., The English language Society, London.   
Coker, M. F., Berky, S., Pandou, C. (1998). New development in acute 
diarrhoea current problem. Paediatrics. 24: 15-17. 
 71
Collins, F. M. (1974). Vaccines and cell mediated immunity. Bacteriol. 
Rev., 38: 371-401. 
Couper, M. (1987). Opioid action on the intestine: The importance of the 
intestinal mucosa. Life Sci. 41: 917- 925. 
Cruickshank, J. R., Duguid, J. P., Marimion, B. P. and Swain, R. H. 
A. (1973). Medical Microbiology, 12th edition. 11. Churchill Livingstone. 
London, UK. 
Deleeuw, P. W., Ellen, D.J., BalRen jam VAN and Straver, P. J. 
(1980). Rotavirus infection in cattle. Efficacy of oral vaccination in 
endemically infected herds. Res. Vet. Sci., 29: 142- 147. 
Dickle, C. W., Klinkerman, D. L. and Petrie, R. I. (1978). 
Enterotoxaemia in two foals. Journal of the American Veterinary Medical 
Association. 173: 306-307.  
Durham, P. J. K. Hassard, L. E., Armstrong, K. R. and Naylor, J. M. 
(1989). Coronavirus associated diarrhoea (Winter dysentery) in adult 
cattle. Can. Vet. J., 30 (10): 825- 827. 
 
EL Gazali, G. E. B. ; Abdalla, W. S. ; El egami, A. A. B. ; AL 
Magboul, A. Z. I. and Daim Hamad, A. A. (2004). Aromatic plants of 
the Sudan, National Center for Research. Khartoum University press. 
 
Farack, U. M.; Kantz, U. and Loescke, K. (1981). Loperamide reduces 
the intestinal secretion but not the mucosal cAMP accumulation induced 
by cholera toxin. Naunyn Schmiedebergs Arch. Pharmacol. 317: 178-179. 
 
Farthing, M. J. G. (2002). Novel targets for the control of secretory 
diarrhoea. Gut 50(suppl. 111): 15-18. 
 72
Fernelius, A. L. (1973). Comments on immunity to Neonatal calf 
diarrhoea viruses and parvovirus infections in calves. Journal of the 
American Veterinary Medicine Association. 163: 887–888. 
Ferris, D. H. (1971). Epizootiology of porcine transmissible 
gastroenteritis. Ad. Vet. Sci. Comp. Med., 17: 57–86. 
Fleetwood, A. J., Edwards, S. and Foxwell, P. W. (1989). Winter 
dysentery in adult cattle. Vet. Rec., 125 (22): 533-554. 
Gaginella, T. S., Stewart, J. J., Olson, W.A., Bass, P. (1975). Actions 
of ricinoleic acid and structurally related fatty acids on the 
gastrointestinal tract II. Effects on water and electrolyte absorption in 
vitro. J. Pharmacol. Exp. Ther; 195: 355-361.   
Galvez, J.; Crespo, M. E.; Zarzuelo, A.; De Witte, P. and Spiessens, 
C. (1992). Pharmacological activity of a procyanidin isolated from 
Sclerocarya birrea bark: Anti-diarrhoeal activity and effects on isolated 
guinea-pig ileum. School of Pharmacy, University of Granad, Belgium. 
Galvez, J.; Zarzuelo, A.; Crespo, M. E.; Utrilla, M. P.; Jiménez, J.;  
Spiessens, C. and de Witte, P. (1991). Anti-diarrheic activity of 
Sclerocarya birrea barks extract and its active tannin constituent in rats. 
Departamento de Farmacologia, Facultad de Farmacia, Universidad de 
Granada, Granada, Spain. Laboratory of Pharmaceutical Biology and 
Phytopharmacology, K. U. Leuven, Leuven, Belgium. 
Gamal, E. D; Mahgoob, S. EL; Awatif, A. B and Mohammed, G. M. 
(1997). Medicinal Plant of Ingassana area, Research Institute for 
Medicinal and Aromatic Plants. National Center for Research, Khartoum, 
Sudan. 
Heyworth, M. E. (1985). Pathophysiology of small intestine. The 
biological principles of disease. By Smith, L. H. and Their, S. O. 2nd ed. 
 73
Saunders, Philadelphia, London, Toronto Mexico city, Rio de Janeiro, 
Sydney, Tokyo and Hong Kong. P. 1211–1212. 
Hornish, M., Salajka, E., Sarmanova, Z., Ulman, L. and Sedlacek, M. 
(1975). Histopathological changes produced by two enteropathogenic 
strains of E. coli in gnotobiotic piglets. J. Comp. Pathol. 85: 277- 283.  
Hyde, M. A. and Wursten, B. (2010). Flora of Zimbabwe: species 
information: Hydnora abyssinica. 
Janke, B. H. (1989). Protecting calves from viral diarrhoea. Symposium 
on neonatal calf diarrhoea Vet. Med., 84: 803-810. 
Jones, R. N., (1996). Impact of changing pathogens and antimicrobial 
susceptibility patterns in the treatment of serious infection in hospitalized 
patients. AM. J. Med. 100 (6A): 35-125.   
Karim, S. M. M. and Adaikan, P. G. (1997). The effect of loperamide 
on prstaglandin-diarrhoea in rats and man. Prostaglandins 13: 321-331.  
Kasper, D. L., Favcl, A. S., Longo, D. L., Brounwald, E., Hauser, S. 
L. and Jameson, J. L. (2005). Principles of Internal Medicine. 16th ed. 
Mc. Craw. Hill. Sydney, New York, London, Philadelphia.  
Koko Waro, J. O. (1976). Medicinal plants of East Africa. East Africa 
literature. Bureau. Kampala, Nairobi, Dar Es Salam. 
Komolafe, O. O., Anyabuike. C. P. and Obaseki, A. O. (1988). The 
possible role of mixed function oxidases in the hepatobiliary toxicity of 
Azadirachta indica. Fitoterapia, LIX: (2), 109-113. 
Kumar, S, Deven, S, Sangraula, H, kumar, V.L. (2001). Anti-
diarrhoeal activity of latex of Calotropis procera. J. Ethnopharmacol. 76: 
115- 118. 
 74
Lambert, G. and Fernelius, A. L. (1968). Bovine viral diarrhoea virus 
and Escherichia coli in neonatal calf enteritis, Can. J. comp. Med., 32: 
440- 446. 
Lambert, H. P. (1979). Clinics in Gastroenterology. W. B. Saunder. 
London. Phladelphia USA. 
Lewis, L. D., Philips, R. W. and Card, C. S. (1973). Pathogenesis and 
treatment of bovine neonatal diarrhoea. JAVMA, 163 (10): 1189-1193. 
Lewis, L. D., Philips, R. W. and Elliot, E. D. (1975). Change in plasma 
glucose and lactose concentration and enzyme activities in the neonatal 
calf with diarrhoea. Am. J. Vet. Res., 36: 413-416. 
Logan, E. F. (1973). Studies on the immunity of the calf to enteric 
colibacillosis. Fellowship thesis, Royal College of veterinary Surgeons, 
London, SWI, 39 pp.    
Logan, E. F. (1974). Colostral Immunity to Colibacillosis in neonatal 
calf. British Veterinary Journal. 103: 405.     
Lolekha, S. (1986). Consequence of treatment of gastrointestinal  
infection. Scand. J. Infec. Dis. (supp), 49:154-159.    
Luderer, J. R., Dermers, I. M., Hayes, A. T. (1980). Advance in 
prostaglandin and thromboxane research. New York: Raven Press. 
Martin, R. K. (1989). Diarrhoea. Text Book of Veterinary internal 
Medicine disease of the dog and cat vol. Third edition. Ettinger, S. J. W. 
B. Saunders Company.    
McBeath, I. (1971). An examination of the influence of husbandry on the 
plasma immunoglobulin in level of the newborn calf using a rapid 
refractometer test for assessing immunoglobulin content. Vet. Rec., 88: 
266. 
 75
 McDonnell, G. and Russel, A. D. (1999). Antiseptic and disinfection 
activity, action and resistance. Clinical microbiology reviews 12, 147-79. 
Mebus, C. A. (1976). Calf diarrhoea induced by corona and reovirus–like 
agent. Modern vet. Practice, 57 (9): 693–698.  
Mebus, C. A., Stair, E. L., Underdahl, N. R. and Twiehaus, M. J. 
(1971). Pathology of neonatal calf diarrhoea induced by reo–like virus. 
Vet. Path. 8: 490– 505. 
Meckes, M., Torres, J., Calzada, F., Rivera, J., Camorlinga, M., 
Lemus, H. and Rodríguez, G., (1996). Antibacterial Properties of 
Helianthemum glomeratum, a Plant Used in Maya Traditional Medicine 
to Treat Diarrhoea.  Programa de Colaboración sobre Medicina Indígena 
Traditionally Herbolaria. Centro de Investigations Ecológicas del Sureste, 
San Cristóbal de las Casas, Edo. De Chiapas, México.  
Medani, A. B. (2003). Toxicity of Poly Damac (Polydiallyl-dimethyl 
Ammonium Chloride) and Alum (Aluminum Sulphate) to Nubian goats 
and New Zealand rabbits. Ph.D, Thesis, University of Khartoum, Sudan.  
Medterms dictionary (2007). Definition of Diarrhoea. Medterms.com. 
http://www.medterms.com. 
Moore, D. A. (1989). Minimizing morbidity and motility from 
cryptosporidiosis. Vet. Med. 84, 811–815.  
Morin, M.; Lariviere, S.; Lallier, R.; Begin, M.; Roy, R. and Ethier, 
R. (1978). Neonatal calf diarrhoea: Pathology and microbiology of 
spontaneous cases in diary herd and incidence of the enteropathogens 
implicated as etiological agents. Proceeding second International 
symposium on neonatal diarrhoea. October 3-5. University 
Saskatchewan. Canada. P 347- 369. 
 76
Murugesan, T., Ghosh, L., Mukherjee, K., Das, J., Pal, M. and Saha, 
B. P., (1999). Evaluation of anti-diarrhoeal profile of Jussiaea 
suffruticosa Linn. Extract in rats Calcutta, India. 
Musselman, L. J. (1997). Hydnora abyssinica A.Braun ex Schweinf. 
(Family Hydnoraceae). FZ, Vol 9 Part 2, page 16. 
Newman, L. E., Whitehair, C. K. and Mullaney; T. P. (1978). Immune 
response of the bovine fetus to in-utero vaccination with bovine 
coronavirus. In ACRES, Proc. 2nd . Int. Symp. Neonatal Diarrhoea. Pp. 
457-464. 
Niemegeers, C. L. E.; Lenaerts, F. M. and Janseen, P. A. J. (1974). 
Loperamide (R- 18553), A novel type of anti-diarrhoeal agent. Part 1: in 
vitro oral pharmacology and acute toxicity. Comparison with morphine, 
codeine, diphenoxylate and difinoxine. Arzneimittelfforsch 24: 1633-613. 
Nwude, N. (1979). Poisonous Plants in Nigeria, PhD. Thesis, Ahmadu 
Bello University Press, Zaria, Nigeria. 
Ojewole, J. A. O.; Awe, E. O. and Nyinawumuntu, A. (2008). 
Antidiarrhoeal activity of Hypoxis hemerocallidea Fisch. & C. A. Mey. 
(Hypoxidaceae) Corm ( African potato ) aqueous extract in rodents. 
South Africa. 
Ott, G. L. (1937). Studies on the relationships between colon bacilli and 
the protozoan parasite, Eimeria tenella, of chickens. A Dissertation 
Presented to the Graduate Council of the University of Florida in Partial 
Fulfillment of the Requirements for the Degree of Doctor of Philosophy  
Patel, N. J.; Gujarati, V, B.; Gouda, T. S.; Venkat Rao, N.; 
Nandakumar, K.; Shantakumar, S. M. (2006). Anti-diarrhoeal activity 
of alcoholic and aqueous extracts of roots of Tylophora indica (Wight and 
Arn.) in Rodents. Pharmacology on line 1: 19-29. 
 77
Pierce, N. F., Carpenter, C. C. J., Elliot, H. Z., Greenough, W. B. 
(1971). Effects of protaglandins, theophylline and cholera exotoxin upon 
transmucosal water and electrolyte movement in canine jejunum. 
Gastroenterlogy; 60: 22-32. 
Pohlenz, J. (1980). Bovine cryptosporidiosis. Egyptian Seminar on the 
mortality of newly born calves. Assuit Vet. Med. J., Vol. 7, supplement 1: 
37-41.  
Pohlenz, J., Moon, H. W., Cheville, N. F. and Bermick, W. J. (1978). 
Cryptosporidiosis as a probable factor in neonatal diarrhoea of calves. 
JAVMA, 172 (4): 452–457. 
Puent, J. L. and Finlay, B. B. (2001). Pathogenic E. coli. In principle of 
Bacterial pathogen. Academic Press. P 387−429. 
Quinn, P. J., Carter, M. E., Markey, B. K. and Cater, G. R. (1999). 
Clinical Veterinary Microbiology Mosby. 
Radostits, O. M.; Blood, D. C. and Gay, C. C. (1994). Veterinary 
Medicine. 8th ed. Educational Low-price Books Scheme (ELBS) with 
Baillière Tindall, London.  
Radostits, O. M.; Gay, C. C.; Blood, D. C. and Hinchcliff, K. W. 
(2000). Veterinary Medicine, A text book of the Diseases of Cattle, 
Sheep, Pigs, Goats and Horses 9th ed. Harcourt Publishers Limited, 
London.   
Rani, S., Ahmed, N. and Rajaram, S. (1999). Anti-diarrhoeal 
evaluation of Clerodendrum phlomidis linn. Leaf extract in rats. J. 
Ethnopharmacol , 68: 315-9.  
 78
Rhodes, M. B., Stair, E. L., McCullough, R. A., McGill, L. O. and 
Mebus, C. A. (1979). Comparison of results using electron microscope, 
immunodiffusion and fluorescent antibody analysis to detect rotavirus in 
diarrheic faecal samples of calves, Can. J. Comp, Med., 43:84–89. 
Rukangira, E. (2001). The African herbal industry constrains and 
challenges. The natural products and cosmeceuticals conference. 
Erborisleria Domani (pub).  
Russel, A. D. (1999). Bacterial Resistance to disinfectants: Present 
knowledge and future problem. Journal of hospital infection 43 (suppl.), 
S57-S68.  
Saif, L. J. and Smith, K. L. (1983). A review of rotavirus immunization 
of cows and passive protection of calves In ACRES, 4th Int. Symp.  
Sanders, D. E. (1985). Field management of neonatal diarrhoea. Vet. 
Clin. N. Amer. Food Anim. Pract., 1 (3): 621- 637. 
SAS (1998). SAS Institute, NC, USA. 
Schalm, O. W. (1965). Veterinary Hematology. Baillière, Tindall and 
Cassell Ltd., London. 
 Schoenian, S. (2009). Sheep and Goat Specialist at the University of 
Maryland’s Western Maryland Research and Education Center. Diarrhoea 
(scours) in small ruminants. University of Maryland Extension.  
Shah, A. J., Gowani, S. A., Zuberi, A. J., Ghayur, M. N., Gilani, A. 
H., (2009). Anti-diarrhoeal and spasmolytic activities of Alstonia 
scholaris L. Drug Discovery and Natural Products Research Unit, 
Karachi-74800, Pakistan.  
 79
Sini, J. M., Umar, I. A., Anigo, K. M., Stantcheva, I., Bage, E. N. and 
Mohammed, R. (2008). Antidiarrhoeal activity of aqueous extract of 
Combretum sericeum roots in rats. African journal of Biotechnology 
Vol.7 (17), pp. 3134-3137. 
Smith, H. W. and Hall, S. S. (1967). Observations by the ligated 
intestinal segment and oral inoculation in pigs, calves, lambs and rabbit; 
studies on Escherichia coli entertoxin. J. Path. Bact., 93: 499-529.  
Snedecor, G. W. and Cochran, W. G. (1989). Statistical Methods, 8th 
ed., Iowa State University press, Iowa, USA. 
Snodgrass, D. R. (1981). Report to cattle project, Tripoli, Libya, on calf 
morality problems experienced on project farms. Anim. Dis. Res. Associ. 
Snodgrass, D. R. (1984). Bovine rotavirus serotypes and their 
significance for immunization J. Clin. Microbiol., 20: 342-346.  
Snodgrass, D. R. and Wells, P.W. (1978a). Passive immunity in 
rotaviral infection. JAVMA: 173, 5 (2): 565-568. 
Snodgrass, D. R. and Wells, P.W. (1978b). The immunoprophylaxis of 
rotavirus infections in lambs. Vet. Rec., 102: 146-148.  
Snodgrass, D. R., Fahey, K. J., Wells, P. W., Campbell, I. and 
Whitelaw, A. (1980). Passive immunity in calf rotavirus infections; 
Maternal  vaccination increases and prolong immunoglobulin GI antibody 
secretion in milk. Infect. Immun., 38: 344-349.   
Snodgrass, D. R., Stewart, J., Taylor, J., Krauuti, F. L. (1982). 
Diarrhoea in diary calves reproduced by feeding colostrum from cows 
vaccinated with rotavirus. Res. Vet. Sci., 82 (1): 70-73.  
Stafseth, H. J. (1931). Studies on the pathology of avian coccidiosis. J. 
Amer. Vet. Med. Assoc. 78: 793–816.  
 80
Straits Times, (2007). Diarrhoea kills 3 times more 
http://www.straitstimes.com. 
Tennant, B., Harold, D. and Reina Guerra, M. (1972). Physiological 
and method factors in the pathogenesis of neonatal enteric infections in 
calves. JAVMA, 161: 993-1007. 
Tyzzer, E. E. (1937). A discussion of gallinaceous birds. Amer. J .Hyg. 
10: 269–383. 
Tzipori, S. (1981). The aetiology and diagnosis of calf diarrhoea. 
Veterinary record. 108: 510- 514. 
Tzipori, S.; Withers, M.; Robins-Drowne, R; Ward, K. L. and Hayes, 
J. (1984). Attachment of E. coli bearing K88 antigen to equine brush 
border membranes. Veterinary microbiology 9: 561-570. 
Umoh, J. U. (1982). Relative survival of calves in a University herd in 
Zaria, Nigeria. Br. Vet. J., 138: 507-514.  
Varley, H. (1967). Practical Clinical Biochemistry. 4th ed., William 
Heinemann Medical Books, Ltd., and Interscience Books Inc., New York. 
Viswanatha, G. L., Srinath, R., Nandakumar, H., Shylaja, and 
Lakshman, K. (2007). Antidiarrhoeal activity of Thespesia populnea in 
rodents. Pharmacology online 3: 222-230.  
Wakeen, A. A. and Dansoury, M. S. (1962). Study of calf losses in a 
herd of Sudanese dairy cattle. Sud. J. Vet. Sci. Anim. Husb. , 3 (2): 
125−132. 
Waltner-Toews, D., Martin, S. W., Meek, A. H., McMillon, I, and 
Crouch, C. F. (1985). A field trial to evaluate the efficacy of a combined 
rotavirus –coronavirus, E.coli vaccine in diary cattle. Canad. J. Comp. 
Med., 49: 1-9. 
 81
Weber, D. M. (1976). The diarrhoeal disease and food born illness. In 
tropical medicine, Hunter G.W., Swartzwelder J.C, Clyde D.F (eds), 5th 
ed. W.B. sounders Co; Philadelphia. 
Wells, P. W., Snodgrass, D. R., Herring, J. A. and Dawson, A. M. 
(1978). Antibody titers to lamb rotavirus in colostrum and milk of 
vaccinated ewes. Vet. Rec., 103: 46-48. 
WHO (1998). Regulatory Situation of Herbal Medicines, A worldwide 
Review. World Health Organization, Geneva, Switzerland. 
http://whqlibdoc.who.int/hq/1998/WHO -TRM-98.1.pdf. 
WHO, (1980). E. coli Diarrhoea Bulletin of the World Health 
Organization 58:23. 
WHO, (1992). Reading on diarrhoea, student, manual WHO the 
management and prevention of diarrhoea. 
Wikipedia, the free encyclopedia, (2007). Manila Bulletin Publishing: 
Diarrhoea causes 1.5 million infant deaths a year__ UN. NIH Publication 
No.07- 2749. 
Wise, C. M., Knight, A. P., Iwias, M. J., Morris, C. J., Ellis, R. P. and 
Philips, R. W. (1983). Effect of salicylates on intestinal secretion of 
calves. AM. J. Vet. Rec., 44 (12): 2221-2225.  
Wondergen, P., Senah, K. A., Glover, E. K. (1989). Herbal Drugs in 
Primary Healthcare. Zimbabwe Science News. 
Woode, G. N.  and Dennis, M. J. (1978). Studies on cross protection 
induced in calves by rotavirus of calves, children and foals. Vet. Rec., 
103: 32–34. 
Woode, G. N. and Bridger, J. C. (1975). Viral enteritis of calves. Vet. 
Rec., 96: 85-88.  
 82
Woode, G. N. and Crouch, C. F. (1978). Naturally occurring and 
experimentally induced rotaviral infection of domestic and laboratory 
animals. JAVMA, 123; 5 (2): 522−526. 
Yanpellewar, S. U.; Sen, S.; Tapas, S.; Mohan, K. M.; Raju, S. S. and 
Acharya, S. B. (2002). Effect of Azadirachta indica on paracetamol- 
induced hepatic damage in albino rats. Phytomed., 10: 391-396. 
Zeman, D. H., Thomson, T. U. and Francis, D. H. (1989). Diagnosis, 
treatment and management of enteric collibacillosis. Vet. Med. Vol. 84, 
794- 802. 
 
 
 
